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1.1 Neuronal development in the mammalian brain The human brain contains more than 1011 neurons that ensure  intricate wiring and connectivity.  Neurons  exhibit  a  characteristic  polarized  morphology  and  thus  harbor typically one axon and multiple dendrites. In humans, the length of an axon ranges from 1 mm to more than 1 m. Neurons make connections via synapses to thousand other neurons and  form  a  complex  network  that  is  responsible  for  transmission  of  information  in  the brain.  In  a  directional  flow,  synaptic  inputs  from  surrounding neurons  are  integrated by dendrites, provoking the generation of an action potential at the soma, which is propagated along the axon to other target cells. In addition to neurons, glial cells provide a supporting framework  to  maintain  neuronal  functionality  and  outnumber  neurons  10‐fold  in vertebrates.  During  neuronal  development,  neurons  undergo  radical  changes  in  their morphology.  Immature  neurons  migrate  long  distances  to  their  target  location  in  the developing brain. This is followed by directed outgrowth of axonal and dendritic processes to  make  synaptic  contacts  with  other  cells,  generating  a  highly  organized  network  of connections between  the different parts of  the brain. Based on electrical  inputs between the  individual  neurons,  the  connections  are  refined  and  adjusted  throughout  adulthood. Neuronal  development  can  be  subdivided  into  different  key  phases,  which  will  be introduced in the following chapters. 
1.1.1 Neuronal induction  Early in vertebrate development, the embryo is separated into three different layers ‐ the endoderm, the mesoderm and the ectoderm. The latter is giving rise to the cells that are destined to become neurons of the central and peripheral nervous system (De Robertis &  Sasai,  1996).  In  the  first  phase  of  neuronal  development,  referred  to  as  neuronal induction,  cells  in  the  ectoderm  are  determined  to  become  neuronal  precursors.  This  is evoked by diffusible molecules, the so‐called neuronal inducers including Noggin, Chordin, Follistatin or Cerberus, which are secreted from dorsal cells of the mesoderm, the so‐called organizer  (Bouwmeester  et  al,  1996;  Hemmati‐Brivanlou  et  al,  1994;  Lamb  et  al,  1993; Piccolo et  al,  1999; Piccolo et  al,  1996; Sasal  et  al,  1995; Zimmerman et  al,  1996). These 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proteins are antagonists of bone morphogenetic proteins (BMPs) that bind to ectodermal cells  to  induce  the  transcription  of  epidermal  genes.  Inhibition  of  the  BMP  signaling pathway  in  turn  induces  the  transcription  of  proneural  genes  followed  by morphogenic changes of the ectodermal cells (Chang & Hemmati‐Brivanlou, 1998). These cells elongate into neuroepithelial cells along the whole axis of the embryo to form the neural tube, which ultimately develops  into  the brain and spinal  cord. Depending on  their  localization along the anteroposterior axis of the neural tube, neuronal precursors are exposed to a gradient of different opposing morphogens including BMP, sonic hedgehong (Shh) and Wnt signals. This  leads  to  the  expression  of  a  specific  blend  of  transcription  factors,  thereby determining the developmental fate of the neuronal precursor (Dessaud et al, 2008; Falk & Sommer,  2009;  Lee &  Jessell,  1999;  Lupo  et  al,  2006).  At  tissue  level,  the  neuronal  tube becomes invaginated and the immature cells line the inner lumen of the ventricular zone. Simultaneously,  neuroepithelial  cells begin  to divide  and  initiate  the process of neuronal proliferation. 




1.1.3 Neuronal migration   Neurons in the developing cortex migrate along RGCs from the ventricular and the subventricular  zone  towards  the  cortical  plate.  After  cell  cycle  exit,  neurons  become polarized  and  extend  a  leading  process  that  senses  the  surrounding  environment  to determine  the  direction  of  movement.  Then,  the  nucleus  translocates  along  the  leading process  in  a  saltatory  pattern,  referred  to  as  nucleokinesis.  Finally,  elimination  of  the trailing  process  leads  to  the  net  movement  of  the  cell  (Ayala  et  al,  2007).  Neurons undergoing  this  locomotor process use  radial  glial  fibers  as  a  guide  to  reach  the  cortical plate, thus the radial glial‐neuron interaction is of crucial importance (Hatten, 1999; Rakic, 1971;  Rakic,  1972;  Sidman  &  Rakic,  1973).  This  interaction  is  mediated  by  various membrane‐bound cell adhesion molecules that include astrotactin, neuregulin or different members of the family of integrins (Adams et al, 2002; Anton et al, 1997; Edmondson et al, 1988; Fishell & Hatten, 1991; Stitt & Hatten, 1990).   The  beginning  of  cortical  neuron  migration  is  initiated  by  the  release  of chemoattractants including brain‐derived neurotrophic factor (BDNF), neurotrophin (NT) 4,  transforming growth  factor  (TGF)α or neurotransmitters  (GABA and glutamate), while the  direction  of  migration  is  guided  by  secreted  molecules  from  the  slit,  netrin  and semaphorin families. At the cortical plate, Cajal‐Retzius cells secrete reelin, whose binding to  its  receptor  triggers  the  phosphorylation  of  Dab1, which  induces  neurons  to  settle  at appropriate  layers  in  the  cortex  (Howell  et  al,  1999;  Howell  et  al,  2000).  Later  born neurons migrate past their predecessors to form layers in an inside‐out manner. 




Figure  1.  Neuronal  polarization  of  hippocampal  neurons  in  vitro.  Shortly  after  plating,  embryonic hippocampal neurons form a lamellipodium (stage 1) and subsequently transform into mutipolar cells with growth cones at  their  tips  (stage 2). Then, one neurite  starts  to grow at a  rapid  rate and breaks  the  initial symmetric morphology  to  establish  polarity  (stage  3).  This  process will  later  become  the  axon,  while  the remaining  neurites  elongate  and  acquire  the  characteristics  of  dendrites  (stage  4).  During  functional maturation, dendritic spines and synapses are formed to establish neuronal networks (stage 5‐6) (modified from Arimura and Kaibuchi, 2007).    In  1994,  Craig  and  Banker  cultured  hippocampal  neurons  to  establish  a  model system to study neuronal polarization in vitro (Craig & Banker, 1994). The morphological changes of hippocampal neurons during maturation follow a well described process (Dotti et  al,  1988),  (Figure 1).  Shortly after plating, neurons extend small protrusions  (stage 1) with growth cones at their tips that develop into equal immature neurites (stage 2). Then, one neurite breaks the cellular symmetry by rapid outgrowth into a long neurite, thereby establishing neuronal polarity  (stage 3). This  longer neurite becomes  the axon, while  the remaining shorter neurites acquire the characteristics of dendrites within the next days in culture  (stage  4).  The  axon  and  dendrites  continue  functional  maturation.  After approximately  seven  days  in  culture  (DIV),  dendritic  spines  and  axon  terminals  form synaptic  contacts,  thereby  establishing  a neuronal network during  functional maturation (stage  5‐6).  Rearrangement  of  the  cytoskeleton  and  microtubules  are  crucial  to  the formation of the axon (Tahirovic & Bradke, 2009). To break the initial neuronal symmetry, intracellular signaling pathways trigger enhanced actin turnover at the growth cone of the future axon (Bradke & Dotti, 1999; Witte & Bradke, 2008).    In  contrast,  the  remaining  neurites  possess  a  rigid  actin  cytoskeleton  that  is  non‐permissive  for  microtubule  protrusions,  thus  inhibiting  enhanced  neurite  elongation (Bradke  &  Dotti,  1999;  Forscher  &  Smith,  1988).  Further,  pharmacological  actin destabilization  induces  the  formation  of  multiple  axons  (Witte  &  Bradke,  2008).  This indicates  the  importance  of  cytoskeletal  dynamics  in  axon  specification  and  neuronal 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polarization. An  array of  proteins  embedded  in different  signaling pathways  converge  at the  level  of  cytoskeletal  regulation.  Among  those,  Rho‐GTPases,  phosphatidylinositol  3‐kinase  (PI3K),  enabled/vasodilator  stimulated  phosphoprotein  (Ena/VASP),  cofilin,  SAD kinases  and  partitioning  defective  (PAR)  complex  proteins  have  been  identified  as  key regulators of neuronal polarity (Barnes & Polleux, 2009; Tahirovic & Bradke, 2009). 
1.1.5 Axonal growth and guidance   The correct wiring of the developing nervous system depends on the ability of axons and  dendrites  to make  contacts with  their  appropriate  synaptic  partners.  During  axonal pathfinding,  the  growth  cone  of  the  axon  detects  guidance  cues  secreted  by  cells  of  the environment.  These molecules  attract  or  repel  the  growth  cone  either  at  close  range  or over  long  distances  (Tessier‐Lavigne  &  Goodman,  1996).  Researchers  have  identified several  families  of  guidance  cues  and  receptors,  including  semaphorins  and  their  plexin (Plex)‐and neuropilin receptors (Pasterkamp & Kolodkin, 2003), netrins and their depleted in  colorectal  carcinoma  (DCC)‐and  UNC5  receptors  (Kennedy,  2000),  slits  and  their roundabout (Robo) receptors (Brose & Tessier‐Lavigne, 2000), and ephrins and their Eph receptors (Kullander & Klein, 2002). Interestingly, the composition of receptors present at the growth cone determines  the direction of axonal growth rather  than a given guidance cue  (Garbe & Bashaw,  2004; Huber  et  al,  2003).  Other  guidance  cues  including  secreted proteins  of  the  Wingless/Wnt  (Lyuksyutova  et  al,  2003;  Yoshikawa  et  al,  2003),  sonic hedgehog (Shh) (Charron et al, 2003) and Dpp/BMP/TGF‐ß (Butler & Dodd, 2003) families contribute  to  axon  guidance.  Furthermore,  neurotrophins,  known  regulators  of  neuronal growth and survival, have been shown to guide axons in vitro (Gundersen & Barrett, 1979; Letourneau, 1978; Song et al, 1997). Directed axonal elongation  is also supported by  the interaction of specific environmental cues with cell adhesion molecules (CAMs), including integrins,  cadherins  and  the  immunoglobin  superfamily.  They  act  as  contact‐dependent attractive/repulsive  cues  and  regulate  selective  fasciculation/defasiculation  of  axons (Tessier‐Lavigne & Goodman, 1996).    The  interaction  of  guidance  cues  with  their  receptors  leads  to  the  activation  of signaling  cascades.  While  it  is  widely  accepted  that  these  signals  converge  at  the cytoskeletal  level  to  control  growth  cone  dynamics,  the  underlying  mechanisms  remain incompletely understood. A crucial event however is the regulation of the activity of Rho‐GTPases.  This  protein  family,  including  the well‐studied members Rac,  Cdc42  and RhoA, 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catalyzes  the hydrolysis  of  bound GTP  to GDP,  thereby  switching  from active  to  inactive state  (Hall,  1998;  Luo,  2000;  Luo,  2002).  Slits,  netrins,  ephrins  and  semaphorins differentially regulate the activity of these small GTPases either by direct interaction (Vikis et  al,  2002; Vikis  et  al,  2000) or  via RhoGEFs  (guanine nucleotide  exchange  factors)  and RhoGAPs (GTPase activating proteins). This leads to remodeling of the cytoskeleton at the growth  cone by  regulating  actin polymerization  and depolymerization  (Welch & Mullins, 2002),  actin/myosin  contractility  (Hirose  et  al,  1998)  and  microtubule  reorganization (Palazzo  et  al,  2001).  Besides  these  extracellular  mechanisms,  cell‐intrinsic  signaling pathways  have  emerged  as  crucial  regulators  of  axonal  morphogenesis.  The  ubiquitin‐proteasome  system  and  several  transcription  factors  have  been  implicated  in  the regulation  of  important  aspects  of  axon  outgrowth  and  pathfinding  (Moore  &  Goldberg, 2011; Polleux et al, 2007).  
1.1.6 Cellular  and  molecular  mechanisms  of  dendrite  growth  and  synapse 
formation   The morphology of different neuronal cell types is also characterized by a cell‐type specific dendritic morphology (Ramón y Cajal, 1911), (Figure 2). Dendritic arborization is regulated  in  a  complex  and  multi‐step  process  that  is  controlled  at  each  stage  both  by extrinsic cues and cell‐intrinsic programs (Jan & Jan, 2003; McAllister, 2000; Urbanska et al, 2008; Wong & Ghosh, 2002).   
 




neurites  obtain  dendrite  characteristics  in  length,  diameter,  growth  rate  and  molecular composition. Second, after extensive elongation  in a defined direction, dendrites  increase in diameter and start branching either via bifurcation of  the growth cone‐like  tips or via interstitial  sprouting  of  a  new branch  from an  already  existing  one.  This  phase  is  highly dynamic since the addition and elimination of new branches occur at a high rate, while only a subset of branches become stabilized. Third, dendrites generate dendritic spines that are the major sites of excitatory synapses. Fourth, after acquiring its final shape, the dendritic arbor  becomes  stabilized,  which  is  accompanied  by  a  decrease  in  structural  plasticity (Craig & Banker,  1994;  Jan &  Jan,  2003;  Scott &  Luo,  2001).  The proper development  of dendritic  arborization  and  hence  the  respective  dendritic  branching  pattern  defines  the amount  of  synaptic  inputs  that  a  neuron  receives.  Thus,  defects  in  dendrite  growth  and patterning can lead to severe dysfunction of the central nervous system (CNS). 
1.1.6.1 Extracellular signals in the control of dendrite growth and branching Dendritogenesis  is  regulated  by  a  combination  of  diffusible  molecules,  cell‐cell interactions and importantly neuronal activity. These diffusible cues include proteins of the neurotrophin  family  (NGF,  BDNF,  NT3  and  NT4),  BMPs,  cpg15,  reelin,  semaphorins  and slits  (Jan  &  Jan,  2003;  McAllister,  2000;  Parrish  et  al,  2006;  Wong  &  Ghosh,  2002). Neurotrophins have been shown to regulate dendrite growth in the developing neocortex, thereby conferring a specific shape to the dendrites of the different cortical layers (Baker et al, 1998; McAllister et al, 1995). Furthermore,  the BMP  family member OP‐1 /BMP7 also modulates  dendrite  growth  and  arborization  in  rat  sympathetic  and  cultured  cortical neurons, respectively (Guo et al, 1998; Le Roux et al, 1999). Another regulator of dendrite growth  is  the  synaptic  activity‐regulated glycosylphospatidylinositol  (GPI)‐linked protein cpg15 that exclusively enhances dendrite growth in projection neurons of the optic tectum in  Xenopus  (Nedivi  et  al,  1998).  Also,  the  well‐established  effect  of  reelin  on  dendrite growth and branching of hippocampal neurons is mediated by mTor, which is in contrast to the  PI3K  and  Akt‐dependent  organization  of  the  cortical  plate  (Jossin  &  Goffinet,  2007). Semaphorin  3A  exerts  its  chemoattractant  function  on  apical  cortical  dendrite  growth through the neuropilin‐1 receptor and selective distribution of the adenylat cylase in apical dendrites  (Polleux  et  al,  1998;  Polleux  et  al,  2000).  In  another  study,  Whitford  and colleagues showed that the slit/Robo interaction regulates dendrite growth and branching in cortical neurons (Whitford et al, 2002). 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In addition to extracellular molecules, cell membrane proteins  including Delta and Notch  (Redmond  et  al,  2000;  Sestan  et  al,  1999),  contactin  (Berglund  et  al,  1999),  cell adhesion molecule  L1  (Demyanenko  et  al,  1999),  ephrinB  and  EphB  (Hoogenraad  et  al, 2005),  N‐Cadherins  (Yu  &  Malenka,  2003)  and  seven‐pass  transmembrane  cadherins (Flamingo,  Celsr2  and  Celsr3)  (Gao  et  al,  2000)  have  been  implicated  in  controlling dendrite growth, branching and tiling, a process that regulates the spacing of the dendritic arbor  (Parrish  et  al,  2007).  Down  syndrome‐related  cell  adhesion  molecule  (Dscam)  is known to mediate dendrite self‐avoidance, which prevents dendrites from making contact with one another, mostly within the same neuron. Alternative splicing of Dscam results in an  enormous  amount  of  different  isoforms;  expression  of  the  same  isoform  by  sister dendrites  triggers mutual repulsion  in several  types of Drosophila neurons (Hughes et al, 2007; Zhu et al, 2006). Interestingly, a similar behavior was reported recently by Smith and colleagues for the diffusible guidance cue UNC6 (Netrin) that forms a complex with UNC40 and  UNC5  in  dendro‐dendritic  contacts,  resulting  in  contact‐dependent  repulsion  in  C. 
elegans  (Smith  et  al,  2012).  Additionally,  since  glial  cells  display  a  crucial  supporting framework  for proper neuronal  functionality,  neuron‐glial  interactions  are  important  for dendrite growth and arborization in both peripheral and central nervous system (Tropea et al, 1988).  Since  dendritic  differentiation  is  accompanied  by  synapse  formation,  neuronal activity  is  another  important  aspect  during  dendrite  development.  While  blocking  or decreasing  afferent  activity  provokes  stunted  dendritic  arbors,  exposure  to  an  enriched environment  can  increase dendrite  growth and branching  in  several brain  regions of  rat pups (Holloway, 1966; Volkmar & Greenough, 1972). In addition, neuronal activity affects the  amount  of  dendritic  filopodia  and  spines  in  many  regions  of  the  brain  (McAllister, 2000).  The  activity‐dependent  effect  on  dendrite  arborization  is  mediated  by  elevated intracellular  calcium  levels  that  activate Ca2+‐dependent downstream signaling pathways (Wong & Ghosh, 2002).  
1.1.6.2 Intracellular mechanisms regulating dendrite growth and branching   Growing  evidence  suggests  that  cell‐intrinsic  mechanisms  including  regulators  of the  cytoskeleton  and  several  transcription  factors  play  a  crucial  role  during  dendrite development.  Since  microfilaments  and  microtubules  represent  the  basic  framework  of dendrites,  changes  in  growth  or  branching  result  from  polymerization  dynamics  of  the 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actin  and  microtubule  cytoskeleton.  Microtubule‐associated  proteins  (MAPs)  including MAP1a,  MAP1B  and  MAP2  have  been  reported  to  play  an  important  role  in  proper dendritic  arbor  morphology  by  stabilizing‐and  cross‐linking  microtubules  to  the  actin cytoskeleton  (Georges  et  al,  2008).  For  example,  depletion  of  MAP2  in  mice  causes  a reduction  in dendrite  length  in hippocampal neurons  (Harada et  al,  2002).  Furthermore, the microtubule‐associated motor proteins Lis‐1 and dynein, members of the microtubule plus‐end  tracking  protein  (+TIP)  family,  regulate  dendrite  arborization  of  Drosophila mushroom‐body neurons (Liu et al, 2000).    In addition  to cytoskeletal  regulators,  transcriptional  regulation contributes  to  the refinement  of  dendrite  arbor  formation  (Urbanska  et  al,  2008).  Wu  and  colleagues demonstrated  the  importance  of  transcription  in  activity‐regulated  dendrite  growth  in BAF53b knockout mice. BAF53b, which is exclusively found in neurons, is a subunit of the chromatin‐remodeling Brg/Brm‐associated factor (BAF) complex (Olave et al, 2002), which regulates the accessibility of transcription factors to interact with DNA by ATP‐dependent chromatin  remodeling.  Together  with  the  Ca2+‐dependent  transcriptional  coactivator CREST,  nBAF  regulates  the  transcription  of  genes  involved  in  dendrite  growth. Interestingly,  BAF53b  knockout  mice  were  impaired  in  activity‐induced  dendrite outgrowth, which was similar to the defects in CREST knockout mice (Aizawa et al, 2004). Wu and colleagues found that BAF53b is required for the recruitment of the nBAF/CREST complex  to  the promoter region of dendrite growth regulating genes,  thereby controlling dendrite morphogenesis (Wu et al, 2007).    Another  important  regulator  of  dendrite  growth  is  the  brain‐enriched  proneural bHLH transcription factor NeuroD. Gaudilliere and colleagues showed that RNAi‐mediated knockdown of NeuroD dramatically  impairs dendrite development  in  vitro.  Furthermore, they found that NeuroD is activated through phosphorylation at serine 336 in an activity‐dependent  manner  by  the  Ca2+/calmodulin–dependent  protein  kinase  II  (CaMKII),  thus providing a  link between neuronal activity and the regulation of dendrite morphogenesis (Gaudilliere  et  al,  2004).  In  addition,  neurogenin2,  another  bHLH  transcription  factor, regulates  pyramidal  neuron  morphology  in  vivo  by  specification  of  the  leading  edge polarity  during  neuronal migration  (Hand  et  al,  2005).  This  further  sheds  light  onto  the important  function  of  proneural  bHLH  transcription  factors  during  dendrite morphogenesis. 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 Cux1, a member of the homeobox family of transcription factors, regulates dendrite complexity in cultured cortical pyramidal neurons. While overexpression of Cux1, but not Cux2,  significantly  decreases  cortical  dendrite  length,  knockdown  of  Cux1  by  RNAi increases  the complexity of  cortical neurons. Cux1 has  further been  identified  to act as a transcriptional repressor of the cyclin‐dependent kinase p27, which is a known regulator of the  small  GTPase  RhoA  (Besson  et  al,  2008).  Thus,  Cux1  negatively  regulates  cortical dendrite growth through the downstream factors p27 and RhoA (Li et al, 2010).   Hence, identification of proteins involved in dendrite morphogenesis is an essential step towards understanding the different stages of dendrite development. 
1.2 Neuronal apoptosis during development and disease   Programmed cell death (PCD) is an important physiological process during neuronal development  that  eliminates  excessive  neurons  generated  during  mitosis.  However, neuronal  apoptosis  is  not  restricted  to  the  period  of  brain  development,  but  can  be  a reoccurring  phenomenon  in  the  adult  brain  when  injury  or  insult  trigger  neuronal  cell death.  The  term  apoptosis,  referring  to  the  naturally  occurring  loss  of  leaves  (from  the Greek  words  apo‐away  from  and  ptosis‐fall),  is  used  to  describe  characteristic manifestations during PCD  (Kerr et  al, 1972). Apoptosis  is  a highly  conserved process  in eukaryotes that activates a sequence of signaling cascades (Martin et al, 1988; Metzstein et al, 1998). Morphological manifestations of apoptosis  include shrinkage and condensation (karyopyknosis) of the cell body, fragmentation (karyorrhexis) of the nucleus as a result of intranucleasomal  DNA  cleavage,  nuclear  membrane  breakdown  and  plasma  membrane blebbing, and the formation of apoptotic bodies, which are subsequently phagocytosed by neighboring cells (Compton, 1992; Kerr et al, 1972). In contrast to apoptosis, necrotic cell death  is  a  non‐regulated  form of  cell  death,  characterized by  swellings  of  cell  organelles and release of intracellular components into the intracellular space, thereby provoking an inflammatory  response  (Farber,  1994).  Autophagy  displays  another  mechanism  of  cell death  that  is  evolutionarily  conserved and  involves degradation of  cellular  organelles by lysosomes  (Levine  &  Yuan,  2005).  All  three  forms  of  cell  death  occur  more  or  less frequently in neuronal development and neurodegeneration (Lossi & Merighi, 2003; Yuan et al, 2003). 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1.2.1 The apoptotic cell death machinery and the Bcl­2 family     The death of  a neuron can be  induced by  the absence of  trophic  factors or by  the presence  of  extrinsic  and  intrinsic  apoptotic  stimuli  including  Ca2+,  glutamate,  reactive oxygen  species  (ROS)  or  excitotoxicity  (Figure  3).  These  signals  converge  at  the mitochondrial  apoptotic machinery  to  induce  the  release  of  cytochrom  c,  provoking  the activation of caspases and subsequent cleavage of key cellular components.    Cytochrom c is a soluble 13‐kDa protein that is involved in electron transfer in the mitochondrial  intermembrane  space  (Liu  et  al,  1996).  The  release  of  cytochrom  c  is regulated  by  Bcl‐2  family  proteins,  which  are  critical  regulators  of  cell  death.  They  are divided in pro‐apoptotic (Bax, Bak, etc.), anti‐apoptotic (Bcl‐2, Bcl‐xL, Bcl‐w, etc.) and BH3‐only  (Bid,  Bad,  Noxa,  etc)  proteins  containing  one  or more  Bcl‐2  homology  domains.  In response  to  an  apoptotic  stimulus,  activation  of  certain  BH‐3  only  proteins  causes  the activation of the pro‐apoptotic proteins Bax or Bak at the mitochondrial membrane (Hsu et al, 1997; Nechushtan et al, 2001; Wolter et al, 1997; Zha et al, 1996). Homo‐dimerization of Bax and Bak leads to formation of a pore in the outer mitochondrial membrane, followed by alterations of  the mitochondrial membrane potential  and  the  release of pro‐apoptotic proteins including cytochrom c, second mitochondria‐derived activator of caspases/direct IAP binding protein of low pI (Smac/Diabolo), AIF, HtrA2 or endonuclease G (endoG) (Jiang & Wang, 2000). The anti‐apoptotic Bcl‐2 proteins block cell death by preventing activation and homo‐dimerization of Bax and Bak, thus maintaining the integrity of the mitochondrial membrane.  Hence,  the  decision  of  a  neuron  to  undergo  cell  death  is  dependent  on  the relative levels of pro‐and anti‐apoptotic proteins (Oltvai et al, 1993).   In  a  caspase‐dependent  mechanism,  cytochrom  c  activates  apoptotic  protease‐activating  factor‐1  (Apaf‐1)  and  induces  the  oligomerization  of  Apaf‐1/cytochrom‐c  to form the apoptosome (Zou et al, 1997). This complex recruits and activates procaspase‐9 that  is  subsequently  released  into  the  cytoplasm  to  activate  downstream  caspases including caspase‐3, caspase‐6 or caspase‐7 (Li et al, 1997; Saleh et al, 1999; Srinivasula et al,  1998;  Zou  et  al,  1997;  Zou  et  al,  1999).  Substrates  of  these  effector  caspases  are mediators and regulators of apoptosis, including DNA fragmentation factor 45 kDa subunit (DFF45/ICAD),  75  kDa  subunit  of  respiratory  complex  I  (NDUFS19,  structural  proteins (fodrin  and  gesolin)  and  cellular  DNA  repair  proteins  (PARP,  DNA‐dependent  protein kinase  (DNA‐PK)).  Cleavage  of  these  proteins  causes  many  of  the  characteristic morphological  hallmarks  of  apoptosis  (Degterev  et  al,  2003).  Concomitant  release  of 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SMAC/Diabolo  and  HtrA2  specifically  sequesters  IAP  proteins,  which  are  negative regulators  of  intracellular  caspase  activity  (Suzuki  et  al,  2001;  Verhagen  et  al,  2000). Moreover,  while  SMAC/Diabolo  leads  to  activation  of  caspase‐9,  HtrA2  initiates fragmentation  of  the  DNA.  Alternatively,  apoptosis  is  induced  by  a  caspase‐independent mechanism  through  AIF  and  endoG  (Benn  &  Woolf,  2004).  While  AIF  functions  in  the nucleus downstream of PARP1 to initiate DNA fragmentation and chromatin condensation, the sequence unspecific DNase endoG degrades nuclear DNA (Arnoult et al, 2003; Daugas et al, 2000; Li et al, 2001; Susin et al, 1999; Yu et al, 2002).  
 
Figure 3: Overview of  the  apoptotic machinery  in neurons. Neuronal  apoptosis  can  be  induced  by  the extrinsic activation of death receptors or by a plethora of different apoptotic stimuli inside and outside of the neuron. The death receptor pathway is activated in response to the binding of extracellular ligands, which can either directly lead to the activation of effector caspases through the apoptotic JNK (c‐Jun‐N‐terminal kinase) signaling  pathway  or  can  converge  with  diverse  apoptotic  stimuli  to  initiate  the  apoptotic  cell  death machinery  at  the mitochondria.  This  involves  the  activation  and homo‐dimerization of  pro‐apoptotic BH3‐only  proteins  as  Bax  or  Bak  to  form  a  mitochondrial  membrane  permeability  pore,  which  results  in alterations  of  the  mitochondrial  membrane  integrity.  These  effects  are  accompanied  by  the  subsequent inhibition of anti‐apoptotic Bcl‐2 family members. This is followed by the release of cytochrom c, formation of the apoptosome and subsequent activation of effector caspases to trigger cell death (modified from Benn and Woolf, 2004). 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1.2.2 Programmed cell death during neuronal development   During neuronal  development neurons  are produced  in  excess  and  approximately half  of  them  are  being  weeded  out  by  apoptosis  before  maturation  of  the  CNS.  Thus, neuronal apoptosis is believed to ensure the appropriate ratio of communicating neurons (Oppenheim,  1991).  In  1949,  Viktor  Hamburger  and  Rita  Levi‐Montalcini  demonstrated that the amount of projecting neurons is directly correlated with the number of surviving neurons  (Hamburger & Levi‐Montalcini,  1949).  This  observation  formed  the basis  of  the neurotrophin  theory  suggesting  that  immature neurons  compete  for  limiting  amounts  of target‐derived  neurotrophic  factors.  Only  those  neurons  survive,  which  are  able  to establish  proper  synaptic  contacts  to  obtain  neurotrophic  support,  while  the  remaining neurons subsequently undergo programmed cell death (Cowan et al, 1984). Consequently in  sympathetic  neurons, withdrawal  of  NGF  induces  the  release  of  cytochrom  c  into  the cytosol, activation of caspases and subsequent cell death (Deshmukh & Johnson, 1998). 
1.2.3 Induction of apoptosis in mature neurons    While  the  lack  of  trophic  support  induces  programmed  cell  death  in  developing neurons, apoptosis  in mature neurons can be  induced by several other stimuli. There are two main caspase‐activation pathways – the extrinsic or death receptor‐mediated pathway and the intrinsic pathway that involves the release of cytochrom c (Figure 3). 
1.2.3.1 Apoptotic stimuli and signaling cascades   Extrinsic  apoptosis  can  be  induced  by  the  activation  of  plasma membrane  ´death receptors´  of  the  tumor  necrosis  factor  (TNF)  receptor  family,  which  include Fas/CD95/Apo1, TNF‐receptor 1 (TNFR1), death receptor 3 (DR3), TRAIL‐R1/DR4, TRAIL‐2/DR5  and DR6. Members  of  this  family  are  characterized  by  extracellular  cysteine‐rich repeats and an  intracellular death domain  (DD)  that  is  important  for  the  transduction of the apoptotic signal (Walczak & Krammer, 2000). Extracellular  ligands belong to the TNF superfamily of cytokines including TNF‐α, Fas and Trail. After ligand binding, TNF‐induced apoptosis is mediated by the recruitment of specific adapter proteins and procaspase‐8 to the death domain, thus forming a death‐inducing signaling complex (DISC) (Kischkel et al, 1995; Medema et  al,  1997;  Scaffidi  et  al,  1997). Activation of high  levels of  caspase‐8 by autoactivation within  the DISC complex  leads  to direct activation of caspase‐3, while  low amounts of caspase‐8 require an additional amplification loop that  includes translocation 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of truncated (t)BID to the mitochondria, release of cytochrom c, apoptosome formation and subsequent  activation  of  caspase‐3  (Cryns  &  Yuan,  1998;  Esposti,  2002;  Kischkel  et  al, 2001; Micheau & Tschopp,  2003;  Schutze  et  al,  2008).  Furthermore,  activation  of  Fas  or TNFR1 also activates the c‐Jun N‐terminal kinase (JNK)‐death pathway inducing increased expression of BIM, p53 and FAS/FASL (Ip & Davis, 1998; MacEwan, 2002).  In addition to the TNF family of cytokines, a diverse array of acute or sub‐acute stimuli including hypoxia, oxidative  stress,  DNA  damage,  ribonucleotide  depletion,  oncogene  activation  or  survival factor  deprivation  result  in mitochondrial  damage  and  subsequent  apoptosis. One  of  the most  important  sensors of  cellular  stress  is  the p53  tumor suppressor protein,  a nuclear phosphoprotein that functions as a key regulator of DNA repair, cell cycle progression and apoptosis  (Giaccia  &  Kastan,  1998;  Ko  &  Prives,  1996).  In  response  to  DNA  damage, initiation  of  the  apoptotic  signaling  pathway  involves  the  PI3K‐like  kinases  ataxia‐telangiectasia‐mutated  (ATM),  ataxia‐telangiectasia  Rad3‐related  (ATR)  and  DNA‐PKs, which  in  turn  activate  downstream  checkpoint  kinases  like  Chk1  or  Chk2.  These checkpoint  kinases  then  phosphorylate  p53  and  its  inhibitor  human  double  minute  2 (HDM2). Activated p53 induces transcriptional upregulation of several pro‐apoptotic Bcl‐2 family members  like  Puma,  Noxa,  Bax  and  Bid, which  is  accompanied  by  transcriptional downregualtion  of  Bcl‐2  and  Bcl‐xL  (Jeffers  et  al,  2003).  In  addition,  p53  affects mitochondrial integrity leading to the release of cytochrom c and apoptosis. 
1.2.4 Apoptosis in neurodegenerative diseases Neuronal  apoptosis  of  selective  neurons  in  the  brain  is  a  hallmark  of  various neurodegenerative  diseases,  injury  or  insult.  Several  pathogenic  stimuli  have  been identified  to  induce  neuronal  cell  death  in  mature  neurons.  In  stroke  and  seizure, accumulation of high levels of glutamate induces neurons to undergo excitotoxic cell death (Coyle  &  Puttfarcken,  1993).  Furthermore,  exposure  of  human  neuronal  cells  to  the amyloid  ß  peptide  (Aß)  triggers  apoptosis  through  activation  of  Bax  and  subsequent release  of  cytochrom  c  (Zhang  et  al,  2002).  In  Alzheimer’s  disease,  Aß  is  the  major component of senile plaques in the brain of AD patients (Selkoe, 1989). Aß is produced by proteolytic cleavage of the amyloid precursor protein (APP) by beta‐and gamma‐secretase (Selkoe, 1998). Interestingly, various Aß species with increasing C‐terminal length ranging from Aß1‐40 to Aß1‐50 have been found in the brains of AD patients (Miravalle et al, 2005). Recently, Saito and colleagues showed that Aß1‐43 has a higher toxicity as Aß1‐40 and Aß1‐42 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(Saito et al, 2011). Conversely, also N‐terminal modified and  truncated  forms of Aß have been  identified.  Pyroglutamate‐modified  Aß3‐42  (Aß3(pE)‐42)  and  truncated  Aß4‐42  are  the most  aboundant  forms,  in  addition  to  Aß1‐40  and  Aß1‐42,  found  in  the  hippocampus  and cortex  of  AD  brains  (Portelius  et  al,  2010).  Wirths  and  colleagues  showed  that intraneuronal  accumulation  of  Aß3(pE)‐42  in  the  hippocampus  and  Purkinje  cells  of  the cerebellum leads to cerebellar atrophy, neurological impairment and growth retardation in TBA2  transgenic  mice  (Wirths  et  al,  2009).  This  further  supports  the  modified  amyloid hypothesis  (Wirths  et  al,  2004),  highlighting  the  role  of  intraneuronal  Aß  in  the pathological events seen in AD, especially in neuronal cell death. Neuronal  apoptosis  in  neurodegenerative  diseases  is  also  caused  by  signals within the  cell. Aggregates of misfolded proteins, which are believed  to harbor  toxic properties, are  major  hallmarks  of  Parkinson’s  disease  (PD)  or  polyglutamine  diseases  (Perutz  & Windle,  2001;  Schulz  &  Dichgans,  1999;  Taylor  et  al,  2002;  Zoghbi  &  Orr,  2000).  In  PD, which  is  the  second most  common  age‐related  neurodegenerative  disease,  Lewy  bodies composed  of  aggregated  and misfolded  α‐synuclein  are  formed  (Spillantini  et  al,  1997). Another trigger of apoptosis is oxidative stress. ROS induce mitochondrial failure and DNA damage and are thus implicated in acute and chronic neurodegeneration including stroke, PD and amyotrophic lateral sclerosis (ALS) (Carri et al, 2003; Jenner, 2003; Smith et al, 2000).  Strikingly,  mutations  of  genes  in  inherited  neurodegenerative  diseases  provide valuable insight into mechanisms of cell death and onset of neurodegeneration. Thus, it is crucial to delineate molecular mechanisms in developmental and disease‐related neuronal apoptosis to develop new approaches to prevent and treat neurodegenerative disorders. 




Figure  4.  The  ubiquitin­proteasome  system.  Ubiquitination  of  target  proteins  involves  the  sequential action  of  three  different  classes  of  enzymes  (E1,  E2  and  E3).  In  an  ATP‐dependent  manner,  ubiquitin  is activated  by  the  E1  ubiquitin‐activating  enzyme  and  covalently  bound  to  the  E1  active  site.  The  activated ubiquitin  is  then  transferred  to  an  E2  ubiquitin‐conjugating  enzyme.  The  E2~ubiquitin  complex  is  in  turn recognized by  the E3 ubiquitin  ligase, which mediates  the  transfer of ubiquitin  to  the substrate. Substrates can  either  be  monoubiquitinated,  multimonoubiquitinated  or  polyubiquitinated.  While  Lys11‐and  Lys48‐linked polyubiquitin chains are directly recognized by the proteasome, Lys63‐linked polyubiquitin chains as well  as  mono‐or  multimonoubiquitination  regulate  the  localization,  function  or  interaction  of  proteins (modified from Kawabe and Brose, 2011). Ub, ubiquitin.    Post‐translational  modification  of  target  proteins  with  one  or  more  molecules  of ubiquitin  is  the result of a multi‐step process, catalyzed by  the sequential action of  three different classes of enzymes (Hershko & Ciechanover, 1998), (Figure 4). First, ubiquitin is activated  by  the  E1  ubiquitin‐activating  enzyme  in  an  ATP‐dependent  manner.  The  C‐terminal  glycine  residue  of  ubiquitin  is  covalently  bound  via  a  thioester  linkage  to  a cysteine residue at the E1 active site. Activated ubiquitin is subsequently transferred to an E2  ubiquitin‐conjugating  enzyme.  E3  ubiquitin  ligases  recruit  both  the  E2‐ubiquitin complex and  the substrate and mediate  the  transfer of ubiquitin  to  the substrate protein (Hershko  &  Ciechanover,  1998;  Yi  &  Ehlers,  2007).  A  target  protein  can  either  be monoubiquitinated, multi‐monoubiquitinated or polyubiquitinated.  In addition,  linkage of ubiquitin  to  the  substrate and  chain elongation  can occur via different  lysine  residues of ubiquitin (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 and Lys63). While substrates modified 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by  Lys11‐or  Lys48‐linked  ubiquitin  chains  are  recognized  and  degraded  by  the  26S proteasome,  Lys63‐linked  polyubiquitin  chains  as  well  as  monoubiquitination  and multimonoubiquitination  regulate  the  localization,  function  or  interaction  of  proteins (Komander & Rape, 2012). Thus, the fate of a substrate protein is defined by the nature of its ubiquitin modification.  
1.3.1 RING E3 ligases in focus   In mammals, there are two E1 enzymes, approximately 35 E2 enzymes and over 600 E3  ligases  (Deshaies  &  Joazeiro,  2009),  which  confer  substrate  specificity  (Huang  et  al, 1999).  Interestingly,  E3  ligases  can have more  than one  substrate;  one  substrate  in  turn can be targeted by different E3 ligases (Amati, 2004; Nishitani et al, 2006). There are two major  families  of  E3  ligases,  which  can  be  distinguished  by  the  presence  of  either  a conserved homologous to E6AP carboxyl terminus (HECT) or a really interesting new gene (RING) domain.  These domains  are  intimately  connected with  the mode of  the E3  ligase activity: while HECT E3 ligases exhibit enzymatic activity to bring about ubiquitination of the substrate, RING E3  ligases act as scaffolds by  facilitating  the  interaction between E2s and substrates (Rotin & Kumar, 2009).   
 
Figure 5. Structure of HECT and RING E3 ubiquitin ligases. There are two major groups of E3 ubiquitin ligases, the homologous to E6AP carboxyl terminus (HECT)‐and really interesting new gene (RING)‐type E3 ligases. These two groups differ in their way to transfer ubiquitin to the substrate. A) HECT E3 ligases exhibit enzymatic activity and covalently bind ubiquitin by a conserved catalytic cysteine in the HECT domain during the  transfer  of  ubiquitin  from  the  E2  to  the  substrate.  B)  RING  E3  ligase  can  act  as  single  subunit  or multimeric  ubiquitin  ligases  and  confer  substrate  specificity  to  the  ubiquitination  system.  They  act  as scaffolds  by  facilitating  the  transfer  of  ubiquitin  between  E2s  and  substrates  and  do  not  have  enzymatic activity. C) The RING domain is a type of zinc finger domain, which is characterized by a defined sequence of cysteines and histidines  (CX2CX9‐39CX1‐3HX2‐38(C/H)X2CX4‐48CX2C; X  can be any amino acid)  that  coordinates two  zinc  ions  in  a  cross‐brace  arrangement  (modified  from Rotin  and Kumar,  2009). Ub,  ubiquitin;  E2,  E2 ubiquitin‐conjugating enzyme; C, cysteine; H, histidine; Zn, zinc.  RING E3 ligases display the largest group of E3 ligases with more than 600 different RING E3  ligases expressed  in humans. The RING domain  is a  type of zinc  finger domain  that  is 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characterized  by  a  defined  sequence  of  cysteines  and  histidines  (CX2CX9‐39CX1‐3HX2‐38(C/H)X2CX4‐48CX2C;  X  can  be  any  amino  acid)  that  coordinate  two  zinc  ions  in  a  cross‐brace arrangement (Freemont, 1993). The RING class of E3 ligases can be further divided into  the  plant  homeobox  domain  (PHD)  and  U‐box  families,  which  harbor  small modifications  in  their  RING  domain.  While  PHD  domains,  sharing  a  similar  pattern  of cysteines and histidines with RING E3 ligases, are not involved in ubiquitination (Aravind et  al,  2003;  Scheel  &  Hofmann,  2003),  U‐box  domains,  structurally  related  to  the  RING domain, exhibit E3 ligase activity (Aravind & Koonin, 2000). The ability of the RING domain to mediate the transfer of ubiquitin depends on the direct interaction with the E2 (Zheng et al, 2000). The attachment of  the  first ubiquitin  (chain  initiation) on a substrate  lysine by the  E3  RING  ligase  and  their  E2  can  occur  randomly  or  in  a  chain  initiation  motif‐dependent manner  (Williamson  et  al,  2011).  Elongation  of  the  chain, which  requires  the formation of an ubiquitin‐ubiquitin isopeptide bond, can be performed by the same E2 or in  cooperation  with  a  specific  chain‐elongation  E2  (Deshaies  &  Joazeiro,  2009).  While Ube2S specifically assembles ubiquitin by Lys11‐linkage, Ube2R1 synthesizes Lys48‐linked ubiquitin  chains  (Petroski  &  Deshaies,  2005;  Williamson  et  al,  2009;  Wu  et  al,  2010). Hence,  the  interaction  of  RING  E3  ligases  with  a  specific  E2  determines  the  nature  of substrate ubiquitination.  
1.3.1.1 RING E3 ligases in neuronal development     Over  the  last  decade,  RING  E3  ligases  have  emerged  as  key  players  in  neuronal development,  including  neurogenesis, migration,  axon  and  dendrite  growth  and  synapse formation (for reviews see: (Kawabe & Brose, 2011; Tuoc & Stoykova, 2010; Yi & Ehlers, 2007)).    The generation of neurons early during embryonal development  is  regulated by a complex network of highly ordered signaling events. This involves the transcription factor Pax6,  which  is  a  member  of  the  Pax  family  of  transcription  factors  that  harbor  a  DNA‐binding paired‐box and homeobox domain. Pax6 is highly expressed in RGCs and influences the generation of neuronal cells by controlling cell cycle parameters (Englund et al, 2005; Quinn et al, 2007; Schmahl et al, 1993). Tuoc and Stoykova  identified  the RING E3  ligase Trim11  as  an  interactor  of  Pax6. Moreover,  Trim11  ubiquitinates  Pax6  and  regulates  its degradation  by  the  proteasome  in  cortical  progenitors.  In  addition,  Trim11  is  able  to remove  insoluble Pax6. Overexpression of Trim11 reduces endogenous Pax6 protein and 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subsequently  inhibits neurogenesis, while RNAi‐mediated knockdown of Trim11  leads  to an  increase  of  Pax6  inclusion  bodies  followed  by  cortical  progenitor  cell  death. Interestingly, the expression of Trim11 is controlled by Pax6 (Tuoc & Stoykova, 2008). In this  model,  the  functional  activity  of  Pax6  during  neurogenesis  is  directly  linked  to  its regulation by Trim11.   After neurogenesis, neurons travel long distances to reach their final target position. Famulski  and  colleagues  found  that  the  exit  of  cerebellar  granule  neurons  from  their germinal  zone niche  is  regulated by proteasomal degradation of  Pard3A by  the RING E3 ligase  Seven  in  Absentia  homolog  (Siah).  In  addition,  electroporation  of  the  external granule  layer  (EGL)  at  P8  with  Siah1B  or  Siah2‐specific  RNAis  revealed  an  increase  in cerebellar  granule  neuron  (CGN) migration  towards  the  internal  granule  layer  (IGL)  for Siah2‐RNAi,  but  not  Siah1B  RNAi‐transfected  cells.  However,  overexpression  of  both Siah1B  and  Siah2  blocked  CGN  migration,  which  was  also  shown  for  Pard3A‐RNAi transfected  CGNs.  The  authors  further  showed  that  Pard3A  binding  to  the  junction adhesive molecule C (JAM C) is required for the contact‐dependent integration of migrating neurons  into  the  cerebellar  cortex.  Thus,  Siah  E3  ligases  control  germinal  zone  exit  and neuronal  migration  towards  the  IGL  by  regulation  of  Pard3A  protein  levels  and subsequently the interaction with JAM C (Famulski et al, 2010).   The  E3  ubiquitin  ligase  anaphase‐promoting  complex  (APC)  and  its  associated regulatory subunit Cdh1 were shown to play a critical role during axon morphogenesis and patterning of  the mammalian brain  (Konishi et al, 2004). Cdh1‐APC which was originally identified as cell cycle regulator (Stegmuller & Bonni, 2005) is also highly expressed in the nucleus of postmitotic neurons (Gieffers et al, 1999). Here, Cdh1‐APC exerts its function as E3  ubiquitin  ligase  regulating  the  degradation  of  several  target  proteins,  including  SnoN and the inhibitor of DNA binding Id2 (Lasorella et al, 2006; Stegmuller et al, 2006). SnoN, a member  of  the  Ski/SnoN  family  of  transcriptional  corepressors  (Stroschein  et  al,  1999), regulates  axon  growth  in  postmitotic  neurons  through  transcriptional  induction  of  the actin‐binding  protein  Ccd1  (Ikeuchi  et  al,  2009).  Ubiquitination  of  SnoN  by  Cdh1‐APC stimulates  the  degradation  of  SnoN  by  the  proteasome  and  thereby  inhibits  axon outgrowth (Stegmuller et al, 2006). This is further controlled by the TGFß‐Smad2 signaling pathway  that  recruits  SnoN  to  the Cdh1‐APC‐complex,  thereby  leading  to  its  subsequent degradation (Stegmuller et al, 2008). 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 Another  example  is  the  E3  ligase  Cul7Fbxw8  that  was  shown  by  Litterman  and colleagues  to  regulate  dendrite  patterning  and  Golgi  apparatus  morphology  by ubiquitination  and  degradation  of  Grasp65.  Cullin  RING‐type  E3  ligases  employ  F‐box proteins  as  substrate  specificity  factors.  Fbxw8  that  is  localized  at  the  Golgi  apparatus specifically  interacts with Cullin7. While knockdown of Fbxw7 not only  impairs dendrite growth  but  also  normal  morphology  of  the  Golgi  apparatus,  knockdown  of  the  Golgi stacking protein Grasp65  enhances dendrite  growth  and  elaboration.  Thus,  regulation of the  secretory  pathway  by  the  RING  E3  ligase  Cul7Fbxw8  identified  another  important mechanism  in  the  control  of  dendrite  morphogenesis  (Litterman  et  al,  2011).  These examples demonstrate the pivotal role of RING E3 ligases in neuronal development. 
1.3.1.2 RING E3 ligases in neuronal apoptosis and neurodegenerative diseases   Neuronal apoptosis is important for proper brain formation and has potential roles in  neurodegenerative  diseases.  Modification  of  apoptotic  proteins  by  the  attachment  of ubiquitin  regulates  key  components  in  cell  death‐signaling  pathways.  Several  RING  E3 ligases  have  been  implicated  in  the  control  of  neuronal  apoptosis,  including  Cdh1‐APC, Siah1, Trim17, parkin or Mgrn1.   Cdh1‐APC  function  is  important during cell cycle as well as axonal morphogenesis (Konishi  et  al,  2004;  Sudakin  et  al,  1995). During  cell  cycle,  Cdh1‐APC ubiquitinates  and degrades key mitotic regulators such as cyclin B1 or securin, thereby controlling together with Cdc20‐APC the timely transitions of cell cycle phases. This raised the question if Cdh1‐APC  also  controls  the  degradation  of  cyclins  in  postmitotic  neurons.  Here,  Almeida  and colleagues  showed  that  Cdh1‐APC  prevents  re‐entry  of  postmitotic  neurons  into  the  cell cycle by degradation of cyclin B1. In addition, the authors found that Cdh1 loss‐of‐function triggers  cyclin‐B1‐dependent  entry  into  S  phase,  which  leads  to  neuronal  cell  death (Almeida et al, 2005).    Another inducer of neuronal apoptosis is the RING E3 ligase Siah1. Overexpression of Siah1  in cultured sympathetic neurons  increases cell death, while knockdown of Siah1 upon NGF deprivation decreases neuronal apoptosis. Xu and colleagues proposed a model, in which Siah1 is stabilized upon apoptotic stimuli through interaction with POSH (plenty of SH3s), a scaffold component of the JNK pathway. Subsequently, Siah1 activates the JNK pathway  to  influence  the  neuronal  cell  death  machinery.  Importantly,  the  induction  of neuronal apoptosis is dependent on the E3 ligase activity of Siah1 (Xu et al, 2006). 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 The  RING  E3  ligase  Trim17  was  identified  as  a  critical  regulator  of  the  intrinsic apoptotic  pathway.  Trim17  is  a  member  of  the  tripartite  (TRIM)  family  and  harbors  in addition  to a RING domain, a B‐box  type 1 and a B‐box  type 2,  and a  coiled‐coil domain. While  knockdown of  Trim17  in KCl‐deprived primary neurons  almost  completely  blocks cell  death,  overexpression  induces  apoptosis  in  neurons.  In  contrast,  expression  of  a Trim17 mutant lacking the RING domain has no effect on neuronal cell death. Thus, the E3 ligase  activity  of  Trim17  is  required  for  regulation  of  neuronal  apoptosis  (Lassot  et  al, 2010).   Another  example  is  the  E3  ligase  parkin. Mutations  in  the Parkin  gene  have  been identified  as  the  cause  of  familial  Parkinsonism  (Mata  et  al,  2004).  Parkin mediates  the ubiquitination of itself and many other target proteins including α‐SYN‐interacting protein synphilin‐1, cyclin E or α/β tubulin (Ali et al, 2011). The  importance of parkin´s  function becomes evident as it maintains neuronal viability by protection against different apoptotic stimuli  such  as  α‐synuclein  toxicity  (Petrucelli  et  al,  2002),  proteasomal  dysfunction (Petrucelli  et  al,  2002)  or  endoplasmatic  reticulum  stress  (Takahashi  et  al,  2003). Disruption  of  parkin  function  is  thought  to  induce  accumulation  of  parkin  and  its  target substrates and ultimately  the apoptosis of dopaminergic neurons  (McNaught et  al, 2002; Moore  &  Goldberg,  2011;  Petrucelli  &  Dawson,  2004).  In  addition,  the  RING  E3  ligases dorfin  and  CHIP  are  involved  in  the  progression  of  PD.  While  dorfin  ubiquitinates  α‐synphilin‐1  and  localizes  within  Lewy  bodies  (Imai  et  al,  2002;  Ito  et  al,  2003),  CHIP enhances the E3 ligase activity of parkin (Imai et al, 2002). Furthermore, the importance of ubiquitination becomes apparent in mice lacking the RING E3  ligase  Mahogunin  ring  finger‐1  (Mgrn1),  resulting  in  progressive  spongiform neurodegeneration as well as abnormal patterning of the left‐right (LR) axis and a defect in pigment  type  switching  (Cota  et  al,  2006;  He  et  al,  2003; Miller  et  al,  1997;  Phan  et  al, 2002). Interestingly, Jiao and colleagues reported that RNF157 (Mgrn2) is a homologue of the E3  ligase Mgrn1. They  found a 69% homology between RNF157 and Mgrn1 with  the highest  similarities  at  the  N‐terminal  region  (Jiao  et  al,  2009).  In  contrast,  while Mgrn1 expression  is detectable  in  the brain  as well  as  in heart,  kidney and  liver,  the Cerebellar Development  Transcriptome  Database  (CDT‐DB)  revealed  that  RNF157  is  a  brain‐dominant protein. However, the function of RNF157 in the central nervous system remains elusive. 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1.3.2 RNF157 and its novel interactor Fe65   Fe65,  which  was  identified  as  a  novel  interactor  of  RNF157,  represents  together with Fe65L1 and Fe65L2 a family of multimodular adaptor/scaffolding proteins. The three family members  are  encoded  in humans by  separate  genes on  chromosome 11,  4  and 5, respectively  (Blanco  et  al,  1998;  Bressler  et  al,  1996;  Tanahashi  &  Tabira,  1999). Interestingly,  Fe65  is  the  only  family  member  whose  expression  is  enriched  in  the mammalian brain (Duilio et al, 1991). Here, two splicing variants of Fe65 are produced by alternative  splicing  of  a  6  bp  mini‐exon.  While  the  Fe65  isoform  containing  these  2 additional  amino  acids  inserted  into  the  first  phosphotyrosine  binding  (PTB)  domain  is only expressed  in neuronal  cells,  the expression of  the  second  isoform without  the mini‐exon  is  restricted  to  non‐neuronal  cells  (Hu  et  al,  1999).  Fe65L1  and  Fe65L2  are more widely expressed (Duilio et al, 1998; Guenette et al, 1999; Tanahashi & Tabira, 1999).    The Fe65 protein family shares three conserved protein domains including one WW and two phosphotyrosine binding domains (PTB) in their C‐terminal region (Ermekova et al, 1997; Fiore et al, 1995). All three family members interact with the amyloid precursor protein (APP)  intracellular domain (AICD) through their second PTB domain  in a Tyr682 phosphorylation‐dependent manner (Borg et al, 1996; Duilio et al, 1998; Fiore et al, 1995; Guenette  et  al,  1996;  Zhou  et  al,  2009).  The  interaction  of  Fe65  and  APP  affects  APP trafficking and secretion of Aß (Fiore et al, 1995; McLoughlin & Miller, 2008). Although all Fe65  family  members  can  complex  with  AICD  and  translocate  as  a  complex  into  the nucleus, only Fe65 harbors transcriptional activity.   The  first PTB domain of Fe65 recognizes an NPXY motif  found  in  the  intracellular domain  of  the  cell  surface  lipoprotein  receptors  LRP1  and  ApoER2.  Both  receptors  are connected with APP  via  Fe65  and  facilitate  a mechanism by which  Fe65 modulates  APP trafficking and signaling (Hoe et al, 2006; Trommsdorff et al, 1998).    The WW domain  of  Fe65 binds  to  proline‐rich  sequences  as  found  in Mammalian 
enabled  (Mena)  or  the  tyrosine  kinase  c‐Abl.  Mena,  a  regulator  of  actin  dynamics, colocalizes  with  Fe65  and  APP  in  neuronal  growth  cones  and  synaptic  terminals. Interestingly, the trimeric complex of Mena, Fe65 and APP influences axon branching, cell motility  and  neuronal  growth  cone  formation  (Ermekova  et  al,  1997;  Ikin  et  al,  2007; Perkinton et al, 2004; Sabo et al, 2001; Sabo et al, 2003).   Recent studies have begun to characterize the role of Fe65 in vivo. In C. elegans, Fe65 displays  a  putative  role  in  survival,  since  functional  deletion  of  FEH‐1,  the  single  Fe65 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orthologue  in worms,  causes  embryonic  lethality  or  developmental  arrest  of  the mutant worms in late embryogenesis or the first  larval stage (Zambrano et al, 2002). Conversely, due  to  functional  redundandency,  the  isoform‐specific  Fe65  as  well  as  the  Fe65L1 knockout  mouse  show  neither  cell  death  nor  neuroanatomical  abnormalities.  However, characterization of Fe65/Fe65L1 double knockout mice revealed an increase in embryonic lethality and developmental brain abnormalities in cortex and hippocampus including focal heterotopias, midline  crossing defects and axonal pathfinding abnormalities  (Guenette et al,  2006).  Interestingly,  the  Fe65/Fe65L1  double  knockout  phenotype  resembles  the phenotype  seen  in  APP/APLP1/APLP2  or Mena  knockout mice  suggesting  an  important role for Fe65 together with APP and Mena in brain development (Herms et al, 2004; Lanier et al, 1999).  




2.1 Chemicals and reagents   Chemicals  and  reagents  used  in  this  work  were  purchased  from  AppliChem (Darmstadt, Germany), Roth  (Karlsruhe, Germany), Merck  (Darmstadt, Germany), Becton Dickinson  and  company  (Heidelberg,  Germany),  Sigma‐Aldrich  (Steinheim,  Germany)  or Invitrogen (Darmstadt, Germany). If they were purchased from other companies, it will be indicated  in  the  text.  Applied  protease  inhibitors  used  in  various  protocols  were Dithiothreitol  (DTT,  1mM),  Pepstatin  (1  µg/ml),  Leupetin  (1  µg/ml)  and  aprotinin  (3 µg/ml).  








































Cbc  medium:  BME  [+]  Earle´s  [‐]  L‐Glutamine,  10%  Calf  serum  (heat  inactivated) (Hyclone), 1% PSG and 25 mM KCl  
BME112 medium: 35 mM  Glucose,  10  µg/ml  Insulin,  1%  PSG  in  BME  [+]  Earle´s  [‐]  L‐Glutamine  
 
2xHBSS: 273 mM NaCl, 9.5 mM KCl, 0.0354 mM Na2HPO4x7H2O, 14.8 mM glucose and 41 mM Hepes; pH 7.05 or pH 7.08  









HEK 293T medium: DMEM [+] 4.5 g/l  glucose  [‐]  glutamine  [‐] pyruvate with 10% FBS and 1% Glutamax  
APC lysis buffer: 2% TX‐100, 300 mM NaCl, 100 mM Tris pH 7.2, 4 mM EDTA  
QA buffer: 10 mM Tri pH 7.5, 100 mM KCl, 1 mM MgCl2, 0,1 mM CaCl2, 1 mM DTT  















Vector plasmid  Constructed by  Primer used pBluescript‐U6‐RNF157 RNAi II  A. Matz  14905/14906 pBluescript‐U6‐RNF157 RNAi III  A. Matz  14907/14908 pCMV‐myc‐RNF157  A. Matz  15828/15829 pCMV‐myc‐RNF157‐Res  A. Matz  22180/22181 pCMV‐myc‐RNF157 ΔRING  A. Matz  15828/17434/17435/15829 pCMV‐myc‐DR6  A. Matz  24715/24716 pBluescript‐U6‐DR6 RNAi I  A. Matz  24711/24712 pBluescript‐U6‐DR6 RNAi II  A. Matz  24713/24714 pBluescript‐U6‐DR6 RNAi III  A. Matz  25825/25826 pCMV‐myc‐Wlds *  A. Matz  25156/25157 pGBT9L  A. Matz  15019/15020 pGBT9L‐RNF157bp892‐1932  A. Matz  16334/16335 pGBT9L‐RNF157bp694‐933  A. Matz  17172/17257 pGBT9L‐RNF157bp1‐921  J. Stegmüller  16420/16421 pCMV‐myc‐Fe65aa1‐325  J. Stegmüller  17802/17803 pCMV‐myc‐Fe65aa326‐524  J. Stegmüller  17804/17805 pCMV‐myc‐Fe65aa525‐711  J. Stegmüller  17806/17807 pCMV‐myc‐Fe65aa1‐5245  J. Stegmüller  17802/17805 pCMV‐myc‐Fe65aa326‐711  J. Stegmüller  17804/17807 pCMV‐myc‐Fe65 **  A. Matz  17802/17807 pBluescript‐U6‐Fe65 RNAi I  A. Matz  19774/19775 pBluescript‐U6‐Fe65 RNAi II  A. Matz  19776/19777 pBluescript‐U6‐Fe65 RNAi III  A. Matz  19778/19779 pEGFP‐C2‐RNF157  A. Matz  14864/14763 pEGFP‐C2‐RNF157aa1‐237  J. Stegmüller  14864/17728 pEGFP‐C2‐RNF157aa238‐442  J. Stegmüller  17442/17729 pEGFP‐C2‐RNF157aa443‐644  J. Stegmüller  17444/17730  *  The  Wlds  cDNA  sequence  was  kindly  provided  by  Dr.  Michael  Coleman,  Babraham Institute, England. ** The Fe65 cDNA sequence was kindly provided by Dr. Uwe Konietzko, University Zurich, Switzerland. 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2.9.1 Isolation of rodent neural and non­neural tissue   Dissection of murine tissue was done on a sterilized laboratory bench. Mice or rats were either killed by decapitation or by the administration of CO2. Subsequently, the skull was opened  and  the brain was  taken out.  The desired brain  regions  such  as  cerebellum, cortex, hippocampus and olfactory bulb were isolated using forceps, scalpel and scoop. For non‐neural  tissue,  the  abdomen of  the  animal was  cut  anterior  to posterior  and  the  skin was  fixed  on  the  left  and  right  site.  Lung,  liver,  heart,  kidney,  spleen  and  testis  were isolated.  Tissues  were  either  flash‐frozen  in  liquid  nitrogen  or  processed  directly  by homogenization in the appropriate lysis buffer supplemented with protease inhibitors.  
2.9.2 Preparation of rodent tissue lysates   The murine  tissues  such  as  cerebellum,  cortex,  hippocampus,  olfactory bulb,  lung, liver, heart, kidney, spleen and testis were isolated and homogenized in respective volumes of  ice‐cold  TX‐100  buffer  supplemented  with  protease  inhibitors.  Homogenization  was either  performed  with  a  2  ml  Dounce  or  Ultra  Turrax  (IKA®)  depending  on  the  tissue. Lysates were placed on ice for 30 min and spun for at 13000 rpm for 10 min at 4°C. The supernatant was collected and protein concentration was measured using Bradford. 




incubated with the antibody for 4 hr or overnight at 4°C. Subsequently, 30 μl of Protein A‐sepharose  (Protein  A‐Sepharose™  Fast  Flow,  GE  Healthcare)  was  added.  Protein  A‐sepharose  binds  rabbit  as  well  as  mouse  IgGs,  respectively.  Before  usage,  beads  were washed three times with Co‐IP buffer. Samples were incubated with the beads for 1 hr at 4°C by rotation. Thereafter, samples were centrifuged for 30 sec at 13000 rpm. Supernatant was discarded and beads were washed twice for 5‐10 min at 4°C either with RIPA or TX‐100 buffer to meet the required stringency and then spun as described above.  In the  last step, beads were washed with PBS, spun down and PBS was aspirated off  leaving ~20 μl. Elution  of  the  protein  was  performed  by  pipetting  30  μl  of  sample  buffer  to  the  beads followed by boiling at 95°C  for 5 min. Supernatant and  input were used  for Western blot analysis.  
2.9.5 Subcellular fractionation of cerebellar granule neurons   Cerebellar  granule  neurons  (CGNs) were  grown  in  6 well  plates  for  the  indicated times  in  vitro. At  least  two wells were used per  condition.  CGNs were  first washed once with  PBS.  Then,  300  μl  of  detergent‐free  SCF  buffer  A was  added  and  adherent  neurons were scraped off the culture dish using a cell scraper. Lysates were incubated on ice for 15 min. Afterwards  neurons were  subjected  to  a mechanic  disruption using  a  2 ml Dounce. Nuclei  were  spun  down  for  5  min  at  2000  rpm  at  4°C  and  supernatant  was  used  as cytoplasmic  fraction (PNS). Pellet was washed  three  times  in SCF buffer A supplemented with 0.1% NP40. Nuclei were then lysed in SCF buffer B and incubated rotating for 15 min at  4°C.  Nuclei  were  pelleted  by  centrifugation  at  13000  rpm  for  20  min  at  4°C  and supernatant was harvested as nuclear fraction (NF) for Western blot analysis. 




2.9.7 Determination of protein concentration by Bradford   Determination  of  protein  concentration  was  performed  using  Bradford  Reagent (Bio‐Rad®). The Bradford solution was diluted 1:5  in PBS (pH 7.3). For  the standard 2, 4 and 8 μg of BSA  (bovine  serum albumin)  solution were diluted  in 1 ml of Bradford/PBS solution  in  a  1 ml microcuvette.  To  analyze  the  protein  concentration,  2  μl  of  the  lysate were diluted and mixed in 1 ml of Bradford/PBS solution. The concentration was measured with  a photometer,  (Amersham Biosciences, Ultro  spec 3100 pro)  set  to  the Basis Mode, measuring absorbance (A= ‐log (%/T/100) at 595 nm. 
2.9.8 Detection of proteins by Western Blot analysis Lysates were diluted in sample buffer, boiled at 95°C for 5 min and spun down in a centrifuge. For  analysis  of  protein  expression  30  –  90  μg  of  protein  was  loaded  onto  a  SDS  gel.  The amount  of  total  protein  was  equal  in  each  lane.  The  gel  consists  of  a  stacking  gel  (3,6% acrylamide)  containing  the  wells  and  a  separating  gel  with  either  8  or  10%  acrylamide concentration. First, all reagents of the separating gel were mixed together (Table 1) and then the required amounts of TEMED and 10% APS were added directly before pouring the gel into the gel cast system (Mini‐PROTEAN Tetra Electrophoresis System, Bio Rad®). Gel was overlaid with  isopropanol. After  approximately 30 min of  polymerisation,  isopropanol was  removed and  the  stacking  gel  (Table  1)  was  poured  on  the  top.  A  10  well  comb  was  inserted immediately into the stacking gel. After polymerization, the protein lysates were loaded and separated  in  the gel by electricity  (70 and 130 V). The protein  transfer was performed  in a cooled wet‐blot system (Mini Trans‐Blot® Electrophoretic Transfer Cell, Bio Rad) at 250‐300 mA for 60‐120 min at RT onto a nitrocellulose membrane (VWR). After transfer of proteins, the  membrane  was  blocked  in  wash  buffer  supplemented  with  4%  milkpowder  (Frema Reform)  for  30 min  at  RT. Membrane was washed  three  times  for  10 min  in wash  buffer. Incubation  with  the  primary  antibody  was  performed  for  1  hr  at  RT  or  overnight  at  4°C (summary of primary antibodies used see in 2.8). Membrane was washed three times in wash buffer  for  10  min  at  RT  and  then  incubated  with  the  secondary  antibody  diluted  in  wash buffer with 4% milkpowder for 30‐45 min at RT. The horseradish peroxidase (HRP) coupled secondary  antibody  was  directed  against  the  species  in  which  the  primary  antibody  was generated in (summary of secondary antibody used see in 2.8). Membrane was washed three 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times with wash buffer.  Protein bands were detected using ECL  according  to manufactures instructions  (Pierce  ECL  Western  Blotting  Substrate,  Thermo  Fisher  Scientific)  on  a chemoluminescence  film  (GE  Healthcare).  Films  were  developed  in  an  automatic  film processor (Kodak imaging station).  
Table 1. Preparation of acrylamide gels.   Separating Gel (total volume 7 ml)  Stacking Gel 
(total volume 4.95 ml) 
% Acrylamide  8%  10%  3.9% Acrylamide  2 ml  2.5 ml  0.65 ml Lower buffer  1.875  1.875  1.25 ml Upper buffer H20  3.625 ml  3.125 ml  3.05 ml  
2.10 Immunocytochemistry 
2.10.1 Perfusion of mice and generation of paraffin­embedded brain sections   Mice were  anesthetized  and  then  transcardially  perfused with  2‐5 ml  prewarmed HBSS  (Hank´s Balanced Salt Solution; Lonza),  followed by perfusion with 4% PFA  in PBS until  the  tissue was  fixed using an automated pump (Heidolph, pump drive 5001). Then, brains were  isolated and postfixed overnight  at 4°C  in  a 4% PFA  solution.  Subsequently, brains were dehydrated, embedded in paraffin (MICROM HMP 110; MICROM AP 280) and cut with microtome (MICROM HM 400) into 5 µm thick sections.  
2.10.2 DAB staining of paraffin sections   Mouse  brain  sections were  deparaffinized  in  xylenes  using  two  changes  in  xylene and one  in xylene/isopropanol  for 10 min,  followed by gradual hydration of  the sections through  graded  alcohols:  5  min  washes  in  100%‐,  90%‐,  70%‐,  50%  ethanol  to  H2O.  Antigen unmasking was performed by heat treatment in sodium citrate buffer for 10 min. and cooled  for 20 min  in  the same buffer. Slides were washed  for 5 min  in Tris‐M buffer and the endogenous peroxidase activity was blocked by incubation in 3% H2O2 for 5 min. After one wash with Tris‐M buffer, sections were incubated in the IHC blocking solution for 10  min  at  RT  and  subsequently  incubated  with  the  primary  antibody  diluted  in  the blocking solution overnight at 4°C. Sections were washed  in Tris‐M buffer and  incubated with the biotinylated secondary (Zytomed) antibody for 10 min at RT. After washing with Tris‐M buffer,  sections were  incubated with  the streptavidin enzyme complex  (Zytomed) 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for 10 min at RT, which is linked to the primary antibody through the secondary antibody. Then,  sections  were  washed  in  Tris  buffer  and  incubated  with  the  DAB  (3,3'‐diaminobenzidine)  (DAKO)  solution  for  10  min,  followed  by  two  washes  with  H20  and staining of  the nuclei with haematoxylin. Finally,  sections were dehydrated and mounted with Eukitt (Kindler GmbH). 
2.10.3 Immunocytochemistry of heterologous cells and primary neurons   Heterologous cells or primary neurons were grown for the indicated times on poly‐ornithine  coated  glass  coverslips  (Menzel‐Gläser)  in  a  24 well  plate.  To  fix  the  cells,  the media was removed and cells were washed twice in PBS. Then, 0.5 ml of 4% PFA diluted in PBS was added  to  the wells and  incubated  for 10 min at RT. After  two washes with PBS, cells were permeabilized with 0.5 ml of PBS containing 0.4% Triton‐X 100 for 10 min at RT. Again, cells were washed twice with PBS. To reduce non‐specific binding of the antibody, cells were incubated with blocking buffer for 30 min at RT. Primary antibody was diluted in blocking  buffer  and  incubated  for  either  1  hr  at  RT  or  overnight  at  4°C.  Afterwards, coverslips  were  washed  twice  with  blocking  buffer  and  incubated  with  the  secondary antibody diluted in blocking buffer for 30‐45 min at RT. The secondary antibody is coupled to  a  fluorophore, which  is  either  Cy2  or  Cy3  (Cy2™/Cy3™,  affinity  pure  goat  anti mouse/ rabbit,  Jackson  Immuno Research, West  Grove,  PA,  USA).  Then,  cells were washed  twice with PBS and staining of nuclei was performed using the DNA dye bisbenzimide (Hoechst 33258) for 5 min at RT. Cells were washed twice with PBS and coverslips were mounted upside down on microscope slides (Marienfeld) in mounting media. 
2.11 Qualitative analysis of gene expression 
2.11.1 Isolation of RNA   Rodent non‐neural tissue such as lung, liver, heart, kidney and spleen or neural tissue like cerebellum, cortex and hippocampus were homogenized in 1 ml Trizol reagent using a 2 ml Dounce. Then 1/5 volume (200 μl) of chloroform was added and mixed by inversion of the tube,  followed  by  incubation  for  15  min  on  ice.  The  solution  was  separated  into  3  three different phases by centrifugation at 13000 rpm for 15 min at 4°C. The upper aqueous phase, which contains the RNA, was transferred into a fresh tube and mixed with an equal volume of isopropanol. Samples were kept on ice for 15 min to allow the RNA to precipitate. Thereafter, samples  were  centrifuged  at  13000  rpm  for  15  min  at  4°C.  Pellets  were  washed  in  70% 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ethanol  prepared with  autoclaved water  and  spun  down  at  13000  rpm  for  10 min  at  4°C. Pellets were air‐dried and resuspended in 200 μl autoclaved water. For second precipitation, 70 μl of 3M ammoniumacetate (NH4Ac) and 500 μl 100% ethanol p.a. were added and tubes were  inverted  several  times. Precipitated RNA was  spun down at 13000 rpm  for 20 min at 4°C. Pellets were air‐dried and dissolved in 100 μl autoclaved water. RNA concentration was measured with a spectrophotometer (Amersham Biosciences, Ultro spec 3100 pro). 
2.11.2 cDNA synthesis from total RNA   2  µg  of  total  isolated RNA was  oligo(dt)‐primed  and  transcribed  into  cDNA with  the SuperScript™ III First‐Strand Synthesis for RT‐PCR Kit (Invitrogen™) according to the manual.  
2.12 Expression plasmid construction and cloning 
2.12.1 General DNA construct amplification   All  DNA  constructs were  amplified  using  1.25  units  of  Pfu  DNA  polymerase  and  the corresponding  buffer  with  10  pmol  forward  primer,  10  pmol  reverse  primer  and  10  mM dNTPs (each) in a thermocycler. The optimal cycling parameters were adjusted according to the melting temperature of the primer pair and the amplicon size. The annealing temperature was set at 5°C below the melting temperature of the primer pair and the elongation time at 72°C was calculated according to the polymerase, 1 min for each 500 basepairs of DNA to be amplified. The cycles were repeated 30 times.  
 
PCR Program 1. Denaturation 95°C  3 min   2. Denaturation 95°C  30 sec 3. Annealing x °C  30 sec 4. Elongation 72°C  x min 
 
 go to step 2 for another 29 cycles 5. Final elongation 72°C  5 min   
 The  size  and  the  quality  of  the  PCR  product  was  determined  with  agarose  gel electrophoresis. As marker a 1 kb or 100 bp ladder was used depending on the size of the PCR product. PCR fragments were cut out and extracted using the Nucleo Spin® Extract II Kit following the manual. 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2.12.2 Cloning   Cleaned PCR products and the respective target expression vectors were digested in a minimal volume of 50 μl with the corresponding restriction enzymes for 1‐2 hr at 37°C. Expression  vectors  were  also  digested  subsequently  with  alkaline  phosphatase,  which catalyzes the removal of 5´ phosphate groups of DNA to prevent self‐ligation. PCR products were directly purified using Nucleo Spin® Extract II Kit, whereas expression vectors were analyzed  with  agarose  gel  electrophoresis  on  a  1%  agarose  gel  to  confirm  efficient linearization. Only linearized vector was cut out and cleaned with the Nucleo Spin® Extract II kit. To ligate 16 µl of digested PCR product, 1 µl of digested target expression vector, 2 µl of ligation buffer and 1 µl T4 DNA ligase were mixed together and ligated either 1 hr at RT or  overnight  at  4°C.  Entire  ligation  reaction  was  transformed  into  100  μl  of  chemo‐competent DH5α E. coli cells, incubated on ice for 20 min, heat shocked at 42°C for 1 min and  then replaced on  ice  for 1 min. Afterwards, 1 ml of prewarmed 2xYT media without antibiotics was added and cells were incubated for 1 hr at 37°C. Cells were spun down at 4000  rpm  for  3  min  and  plated  on  a  2xYT  agar  plate  with  50  μg/ml  ampicilline  or kanamycin  depending  on  the  resistance  gene  carried  by  the  vector  for  selection.  Plates were incubated overnight at 37°C.    For verification of positives clones, colonies were picked with an autoclaved pipett tip and transferred into 2 ml of 2xYT media with the appropriate antibiotics. These mini‐cultures  were  incubated  overnight  at  37°C.  Then,  plasmid  DNA  was  isolated  with  an alkaline lysis protocol and subjected to restriction digest to detect successful ligation. The Nucleo Spin® Plasmid Quick Pure was used to purify DNA from confirmed positive clones followed by sequencing analysis by the AGCTLab at the MPI of Experimental Medicine. For alkaline lysis, cell suspension was transferred into a 2 ml tube and spun down for 3 min at 13000 rpm. Pellet was resuspended in 200 µl of GTE buffer with freshly added RNase (5 µl of  10  mg/µl  stock  solution)  and  incubated  at  RT  for  5  min.  400  µl  of  freshly  prepared bacteria lysis buffer was added and mixed gently by inverting the tube. Sample was placed on ice for 5 min. Then, 300 µl of ice cold neutralization buffer (3M potassium acetate) was added, mixed gently and incubated on ice for 5 min. Sample was centrifuged for 5 min at 13000 rpm. Supernatant was  transferred  into a new tube and 540 µl of  isopropanol was added. By mixing the two solutions the DNA was precipitated. Sample was incubated for 15 min at RT and then centrifuged at max speed for 2 min. Pellet was washed once with 70% ethanol,  air‐dried and  resuspended  in 50 µl of H2O. 5 µl of DNA was used  for  restriction 
Materials and Methods 
39 
digestion with appropriate enzymes and analyzed by gel electrophoresis on a 1% agarose gel.   For  transfection  of  plasmid  DNA  into  heterologous  cells  or  primary  neurons, plasmid  DNA  was  amplified  in  chemo‐competent  DH5α  E.  coli  cells  in  50  ml  or  larger volumes  of  2xYT  medium  with  the  appropriate  antibiotics  overnight  in  a  37°C  shaker. Plasmid  DNA  was  purified  with  the  Nucleo  Bond®  Xtra  Midi  EF  kit  according  to manufacturer’s instructions. 
2.12.3 Site­directed mutagenesis of plasmids   Site‐directed  mutagenesis  was  used  to  mutate  the  RNAi  targeting  sequence  in pCMV‐myc‐RNF157 and pCMV‐myc‐Fe65  that  renders  these encoded molecules  resistant to RNAi‐mediated degradation. The primer pairs 22180/ 22181 with 6 silent mutations for RNF157 and 23636/23637 with 4 silent mutation for Fe65 in the sequence were designed according to the stratagene/Agilent technology manual using the provided formula:          Tm = 81.5 + 0.41(%GC) (675/N) % mismatch  N is the primer length in bases and values for %GC and %mismatch are integral numbers. The protocol was  then modified  in  the  laboratory.  15 pmol  primers were used  in  a  PCR reaction using the Pfu DNA polymerase and the respective vector as template (10 ng). The following cycling parameters were used:  
Site­directed mutagenesis PCR Denaturation  3 min   Denaturation  30 sec Annealing (55°)  30 sec Elongation  1 min/500 bp  17 cycles Final Elongation  5 min    Sample was then incubated on ice for 2 min, digested with DpnI for 1 hr at 37°C and chilled on ice for 10 min. 1 µl of the digested PCR product was transformed into chemo‐competent DH5α E. coli  cells, plated on a 2xYT agar plate containing the appropriate antibiotics and incubated  overnight  at  37°C.  Successful  site‐directed  mutagenesis  was  confirmed  by sequencing. 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2.12.4 shRNA design and plasmid construction   The RNAi technology used in this study is based on the expression of short hairpin RNAs from a DNA template under the control of the RNA polymerase III U6 promoter. The oligonucleotide  primers were  designed manually  in  accordance with  the  following  rules. The 5´ sense primer should start either with AA, AG or GG followed by 18 nucleotides of the target DNA  sequence  and  should have  a GC  content  of  45‐60%. This  sequence has  to  be specific for the target gene, should show no homologies to any other genes and contain not more than three adenosines in a row. Additionally, the targeting region should be identical between  mouse,  rat  and  human.  The  target  sequence  is  followed  by  a  modified Brummelkamp loop (TTCAAGCTT, with a unique HpaI restriction site) and the antiparallel target sequence with addition of CTTTTG (= Stop signal for the RNA polymerase III). The 3´ antisense primer is complementary to the sense primer with addition of TTAA at the end. 2 µl of each primer (50 pmol/µl) was resuspended in 46 µl of annealing buffer, incubated for 4 min at 95°C, 10 min at 72°C and slowly cooled down (0.1°C/sec) to RT. Then, 20 µl of the annealed oligonucleotides were phosphorylated in a kinase reaction for 30 min at 37°C. In parallel to primer preparation, the pBluescript‐U6 vector was digested with ApaI, blunted with T4 DNA polymerase, digested with EcoRI and dephosphorylated with  calf  intestinal phosphatase  (CIP).  Finally,  3‐5  µl  of  phosphorylated  oligonucleotides  and  1  µl  of  the pBluescript‐U6 vector were used for ligation overnight at 4°C and transformed into chemo‐competent DH5α  E.  coli  cells.  Verification  of  positive  clones was  done  by  digestion with HpaI and analyzed by gel electrophoresis on a 1% agarose gel.  
2.13 Culture of primary neurons or HEK 293T cells   In  this  study,  all  cell  culture  work  was  performed  under  cell  culture  sterility conditions  in  a  safety  cabinet  (Hera  safe,  Kendro).  Cells  were  grown  in  a  CO2‐incubator (Hera  cell  150,  Kendro)  at  37°C  and  5% CO2.  Primary  cells  as well  as  heterologous  cells were grown on 10 cm culture dishes, 6 or 24 well plates depending on  the experimental requirements.  
2.13.1 Culture of primary cerebellar granule neurons   Primary  cerebellar  granule  neurons  were  prepared  from  isolated  cerebella  of postnatal day (P6) wistar rats. During isolation, cerebella were kept in HHGN medium on ice. Afterwards,  the meninges of  the cerebella were carefully removed under a dissection 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microscope. All following steps were performed under sterile conditions in a safety cabinet. Cerebella  were  transferred  into  a  50  ml  falcon  and  washed  three  times  with  HHGN medium. After  all media was  removed,  5 ml  of TDn was  added and  incubated 10 min  at 37°C followed by 10 min at RT. Then, after three washes with HHGN medium, 4 ml of DnB was added. The cerebella were triturated to a homogenous suspension and placed on  ice for  5  min.  The  supernatant  was  transferred  into  a  50  ml  falcon.  The  remaining  tissue suspension was triturated again with DnB to a homogenous suspension. Both suspensions were combined and centrifuged for 5 min at 800 rpm. The pellet was resuspended in a final volume of 15 ml Cbc medium. Cells were counted in a hemocytometer. Before plating the required amount of cells (10 cm plate‐, 24 well plate – 20x106 cells/well or 6 well plate – 5x106  cells/well),  culture dishes  (with or without  coverslips) were  incubated at  least 30 min  with  poly‐ornithine  at  37  °C  and  washed  twice  with  H20.  At  day  in  vitro  1  (DIV), neurons were treated with the anti‐mitotic agent nucleoside cytosine arabinoside (AraC, 10 mM) to prevent the proliferation of mitotic non‐neuronal cells. Furthermore, cultures were fed with 35 mM glucose at DIV 3 and 5. 
2.13.2 Culture of primary hippocampal neurons   Primary  hippocampal  neurons  were  prepared  from  isolated  hippocampi  of  E18 wistar rat embryos. During  isolation, hippocampi were kept  in 1xHBSS medium (BME [‐] calcium  [‐]  magnesium)  on  ice.  The  following  steps  were  performed  under  sterile conditions  in  a  safety  cabinet. Hippocampi were washed  three  times with  1xHBSS.  After reducing the media to 1.8 ml, 300 μl 1xTrypsin was added to the tissue and incubated for 10 min at 37°C. Then, hippocampi were washed three times with 1xHBSS and triturated in 1 ml hippocampal plating media to a homogenous suspension with freshly added DNase (2 μg/μl). Suspension was centrifuged at 4°C for 5 min at 800 rpm. Pellet was resuspended in 5 ml plating media and cells were counted in a hemocytometer. Before plating the required amount of cells (24 well plate – 60x105 cells/well for transfection or 10x105 cells/well for immunocytochemistry or 6 well plate – 3x106 cells/well), culture dishes (with or without coverslips) were coated with poly‐ornithine diluted in PBS for at least 30 min at 37 °C and washed  twice with  H20.  At  DIV  1,  plating media was  exchanged  to  hippocampal  growth media. 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2.13.3 Culture of HEK 293T cells   Cell culture work was performed in a safety cabinet. HEK 293T cells were grown in HEK 293T media. For normal maintenance of HEK 293T cells, cells were grown in a 10 cm dish. Cells were split when the plate was ~ 90% confluent. After removal of the media, the plate was washed once with PBS and 1 ml of 1xTrypsin was added onto the 10 cm culture dish. After ~ 1 min incubation at 37°C in the CO2‐Incubator, adherent cells were removed from  the  plate  by  adding  9  ml  of  medium  and  subsequent  pipetting  up  and  down.  The homogenous  trypsin‐cell  suspension  was  centrifuged  at  4°C  for  5  min  at  800  rpm.  The supernatant was discarded and cells were  resuspended  in 5 ml medium. Cell  suspension was placed either into 6 well or 10 cm plates with preincubated medium and distributed by shaking. For a 10 cm plate 1 ml and  for a 6 well plate 180 µl of  the  cell  suspension was used. 
2.14 Transfection of primary neurons and HEK 293T cells   The introduction of plasmid DNA into neurons or HEK 293T cells was done using a calcium phosphate  transfection method. For both protocols  the  same 2xHBSS buffer was used. 
2.14.1 Transfection of primary neurons   Primary cerebellar granule neurons (CGNs) were transfected at  the  indicated time points. The conditioned culture media was collected and incubated in 37° incubator. CGNs were washed twice with prewarmed DMEM (+ 4,5 g/l glucose [‐] glutamine [‐] pyruvate) and starved in a 5% CO2 incubator with 0.5 ml (per well of a 24 well plate) fresh DMEM (+ 4,5 g/l  glucose  [‐]  glutamine  [‐] pyruvate). During  this  time,  the DNA/calcium phosphate precipitate was prepared.  The DNA was diluted  in  18 µl  of  sterile water  and  first mixed with 2 µl of 2,5 mM CaCl2, then with 20 µl of 2xHBSS. The precipitate was allowed to form complexes for 10 min at RT. 40 µl of the mixture was added drop‐wise to the culture, mixed gently and incubated at 37°C for 5‐18 min depending on the experimental design. Neurons were then washed twice with DMEM (+ 4,5 g/l glucose [‐] glutamine [‐] pyruvate) and the aforementioned conditioned media was added.  
2.14.2 Transfection of HEK 293T   One  day  prior  to  transfection,  confluent  HEK  293T  cells were  split  from  a  10  cm plate into a 6 well plate format. Since the uptake of the precipitated DNA is related to the 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presented  surface  area  of  the  cell  to  the  media,  cells  were  split  in  a  1:30  manner.  The following volumes were adjusted for one well of a 6 well plate. 10 ng – 2 µg plasmid DNA was diluted in 90 µl sterile water. For precipitation, DNA solution was mixed with 10 µl 2,5 M CaCl2  followed by  the  addition of  100 µl  2xHBSS  and mixed  gently. DNA  solution was incubated for at least 10 min at RT and then added drop‐wise to the cells. Transfected HEK 293T cells were kept in culture either three days for co‐immunoprecipitation analysis and four days for validation of vector‐based RNAis. 
2.15 Analysis of neuronal morphology   Neurons were  prepared  as  described  in  2.13.1  or  2.13.2  and  transfected  at DIV  4 using  the  calcium  phosphate  transfection  method.  For  loss‐and  gain‐of‐function experiments, neurons were cultured in a 24 well plate and transfected with the respective expression  plasmids  together with  an  expression  plasmid  for  GFP  (0.3  µg)  and  the  anti‐apoptotic protein Bcl‐xL  (0.3 µg)  to avoid any effects of  these manipulations on neuronal survival.  The  calcium  phosphate  precipitate  was  added  drop‐wise  on  granule  neurons starved for 45 min for 15 min. After fixation with 4% PFA at the appropriate time points, neurons  were  subjected  to  immunocytochemistry  using  a  polyclonal  GFP  antibody. Analysis  of  axonal  and  dendritic  morphology was  carried  out  by  capturing  at  least  30 random  pictures  of  GFP‐positive  neurons  in  a  blinded  manner  using  a  fluorescence microscope at 20x magnification. Axonal and dendritic length was measured from the same granule neuron using ImageJ 1.410 software (http://rsb.info.nih.gov/ij). 

















Z­buffer  (1L):  16.1  g Na2HPO4  x  7H20,  5.5g NaH2PO4  x  7H20,  0.75g KCl,  0.246g MgSO4  x 7H20 with pH 7.0  
X­gal stock: 20 mg/ml diluted in Dimethlyformamid (DMF), stored at ‐20°C 
2.17.2 Generation of Gal4 DNA­BD/bait construct   pGBT9L‐RNF157bp892‐1932  and pGBT9L‐RNF157bp694‐933 were  amplified by PCR  from pCMV‐myc‐RNF157 with  the primer pairs 16334/16335 and 17172/17257,  respectively. The  pGBT9L‐RNF157bp1‐921 was  generated  by  J.  Stegmüller  using  the  primers  16420  and 16421.  Constructs  were  confirmed  by  restriction  digestion,  gel  electrophoresis  and sequence analysis. 
2.17.3 Transformation of bait plasmid into yeast (small scale transformation)   Transformation  of  the  yeast  strain  CG‐1945  was  performed  using  a  heat  shock procedure. The CG‐1945 yeast strain  is auxotroph for tryptophan and  leucin and harbors the lacZ and HIS3 reportergene under the control of the Gal4 promoter. Stored yeast cells at  ‐80°C were plated on a YPD plate and inoculated at 30°C. One single colony was grown at 150 rpm in liquid YPD medium at 30°C for one or two days. About 5 ml of the culture was pelleted by centrifugation at 5000 rpm. The following reagents were added to the pellet in the same order and vortexed softly after each reagent: 20 µg herring sperm DNA + 1 µg „bait“ DNA, 500 µl PLATE‐mix (for 10 ml: 8 ml 50% PEG‐4000, 1 ml 1 M LiAc and 1 ml 10x TE) and 20 µl DTT. The  transformation was  incubated at RT  for 6‐8h without shaking. After 7 hr the mixture was heat‐shocked for 10 min at 42°C and chilled at RT  for 5 min at RT. Yeast cells were harvested by centrifugation  for 20 sec at 2000 rpm, dissolved in 100 µl ddH20 and plated (20 µl and 80µl) on the appropriate selective plate ([‐]Trp  for analysis  if yeast cells have  incorporated  the „bait“ plasmid or on  [‐]His plates  to determine  auto‐activation  of  the  His‐reportergene  by  the  „bait“  plasmid).  As  negative control  a  transformation  without  „bait“  was  performed.  Yeast  cells  were  grown  for  2‐3 days at 30°C. 
2.17.4 Transformation of yeast cells with cDNA library (large scale transformation)   The  cDNA  library  used  in  this  study was  a  postnatal mouse  brain MATCHMAKER cDNA library (Lot: 6090287, Clontech). 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 Yeast colonies containing the „bait“ plasmid was inoculated overnight in 10 ml of SD [‐]Trp medium of which 5 ml were grown in a second 100 ml SD [‐]Trp overnight culture. Yeast cells were pelleted by centrifugation for 3 min at 2500 rpm and resuspended in 300 ml of prewarmed YPD medium (OD 0.2‐0.3). Yeast cells were grown to OD of 0.7‐0.8 and harvested by centrifugation for 4 min at 4500 rpm at RT. Pellet was washed once in 40 ml ddH20  and  again  pelleted.  The  following  reagents  were  added  to  the  pellet  in  the  same order for transformation of the cDNA library:  14.4 ml 50% PEG‐4000, 2.16 ml 1 M LiAc, 0.3 ml herring sperm carrier DNA (10 mg/ml), 0.625 ml plasmid library (250 µg) and 0.825 ml ddH20. The transformation was mixed gently and incubated at 200 rpm for 30 min at 30°C. Then, 2 ml of DMSO was mixed gently and yeast cells were heat shocked for 30 min at 42°C. Yeast  cells  were  pelleted  for  30  sec  at  3000  rpm,  resuspended  in  8  ml  of  ddH20  and incubated at RT for 10 min. 250 µl of transformed yeast cells were plated per [‐]His [‐]Trp [‐]Leu [+] 50 mM 3‐AT plates (15 cm diameter) and incubated for 5 days at 30°C.  Colonies with a diameter ≥ 2 mm were replica plated for analysis. To eliminate false‐positive clones, a ß‐galactosidase  assay was performed with one of  the  replica plates  three days  later. A nitrocellulose  membrane  was  placed  on  the  agar  plate  for  1  min,  incubated  in  liquid nitrogen  for 30  sec,  thaw at RT and placed with  colonies  facing up on a whatman paper which was  soaked  in  Z‐buffer/  X‐gal  solution  (for  15  cm  plate:  10 ml  Z‐buffer,  27  µl  ß‐Mercaptoethanol,  167 µl  x‐Gal  stock)  for 30 min – 3 hr depending on  the  color  reaction. Positive indigo‐blue colored colonies were selected for further analysis. 
2.17.5 Isolation of plasmid DNA from yeast   Plasmid DNA of positive yeast clones was extracted from a 5 ml overnight culture. Cells were pelleted in a 1.5 ml tube by centrifugation and lysed together with acid‐washed glass beads  in 250 µl Lysis buffer A1 (NuclepSpin®Plasmid QuickPure). Glass beads were spun  down  and  isolation  of  plasmid  DNA  was  performed  according  to  the  manual  of NuclepSpin®Plasmid QuickPure Kit. 





2.18.1 Extraction of genomic DNA from mouse tails   Tail  biopsies  incubated  in  200  µl  of  lysis  buffer  supplemented  with  NaCl  and Proteinase K were incubated for 3 hr or overnight at 55°C. Samples were gently shaken and spun at 13000 rpm for 10 min at RT. Supernatant was mixed with 0.5 ml 100% ethanol p.a., followed by centrifugation at 13000 rpm for 10 min at RT. The supernatant was discarded and the precipitated DNA was washed with 70% ethanol. Then, the DNA was air‐dried and dissolved  in  50‐100  µl H20.  Subsequently,  1  µl  of  genomic DNA was  used  for  PCR‐based genotyping. 
2.18.2 RNF157 Genotyping PCR   The PCR reactions for the RNF157 gene trap line were performed with the GoTaq® DNA  polymerase  according  the  manufacturer’s  protocol.  The  primer  pair  25173/25172 was used to amplify the wild type allele, whereas the mutant allele was amplified using the primer pair 25171/25172. The following PCR program was used to genotype the RNF157 gene trap mice:        
2.19 Statistics   Statistical  analysis was  performed  using  GraphPad  Prism  5.0c  software.  The  data was analyzed by unpaired Student’s  t‐test and one‐way or  two‐way ANOVA (ANalysis Of 
VAriance). Errors are displayed as standard error of the mean (SEM).   





3.1 Characterization of the E3 ligase RNF157   The ubiquitin‐proteasome system (UPS) has emerged as a crucial regulator of brain development. Since E3 ligases are the most numerous components of the UPS, I sought to identify brain‐dominant candidates to unravel their role in neurons. Using the information of  the  Cerebellar  Development  Transcriptome  Database  (CDT‐DB),  I  found  an  E3  ligase with brain‐dominant expression pattern:  the RING  finger protein RNF157. Aside  from  its striking expression, RNF157 shares a high level of similarity with the E3 ligase Mahogunin RING  finger‐1  (Mgrn1),  which  has  been  previously  implicated  in  spongiform neurodegeneration (He et al, 2003). Owing to the fact that RNF157 is an uncharacterized E3 ligase, reagents were unavailable and the analysis of RNF157 function thus required the generation of tools. 





Figure 6. Protein sequence alignment for the RING domain of mouse, human and rat RNF157. The RING domain is evolutionary conserved between species.    Rat RNF157 was amplified in 2 fragments from brain tissue with the oligonucleotide primers (14758/14759; 14760/14761) designed on the basis of the predicted rat RNF157 cDNA sequence. The PCR reaction with the first primer pair did not give any product. After further sequence analysis a second conserved in frame start‐codon was found in all three analyzed  RNF157  cDNA  sequences  (Appendix  5.1).  Amplification  of  rat  RNF157  with  a sense‐primer (14798) based on this sequence resulted in a PCR product. This shorter rat RNF157 sequence was used for all experiments described in my study.  




Figure 7. Brain­dominant expression of RNF157 in the brain. A) Reverse transcriptase polymerase chain reaction (RT‐PCR) analysis showing the expression of RNF157 in rat cerebellar granule neurons (DIV 6/8), OLI‐neu cells and primary astrocytes  in vitro. B) RT‐PCR analysis showing the expression of RNF157 in the indicated  tissues  collected  from  wild  type  postnatal  day  (P)  12  rat.  GAPDH  served  as  loading  control.  C) Indicated  rat  tissue  lysates  at  P12  were  subjected  to  immunoblotting  using  the  RNF157  and  14‐3‐3ß antibodies. The latter served as loading control. Arrow indicates RNF157. 





Figure 8. Developmental expression of RNF157 in the brain. A) Lysates of cerebellar granule and cortical neurons  prepared  from  P6  or  E18  rats  respectively  and  placed  in  culture  for  the  indicated  days  were immunoblotted using the RNF157 and 14‐3‐3ß antibodies. The latter served as loading control (Courtesy of A.  Holubowska).  B)  Crude  lysates  of mouse  cerebellum,  cortex  and  hippocampus  isolated  at  the  indicated days  were  subjected  to  immunoblotting  using  the  RNF157  antibody.  14‐3‐3ß  served  as  loading  control (Courtesy of A. Holubowska). E, embryonic; P, postnatal day. 
3.1.2.1 Subcellular localization of RNF157 in neurons   To  identify  the  subcellular  localization  of  RNF157,  I  performed  subcellular fractionation of cerebellar granule neurons at DIV 8. Cerebellar granule neuron lysate was sequentially separated into postnuclear supernatant (PNS) and nuclear fraction (NF). Equal amounts of protein from each fraction were subjected to Western blot analysis and probed with  the  RNF157,  Sp1  or  14‐3‐3ß  antibodies.  The  latter  two  served  as  markers  for  the nuclear  fraction and postnuclear supernatant, respectively.  I  found that RNF157  localizes to the postnuclear supernatant in cerebellar granule neurons suggesting that RNF157 is a cytoplasmic protein (Figure 9).  
 
 
Figure  9.  Cytoplasmic  localization  of  RNF157  in 




  In  order  to  characterize  the  subcellular  localization  of  endogenous  RNF157  in neurons, cerebellar granule neurons and hippocampal neurons  in culture were subjected to  immunocytochemistry  using  the  RNF157  antibody.  Here,  RNF157  localized  to  the cytoplasm  and  neurites  in  both  neuronal  cell  types  and was  excluded  from  the  nucleus (Figure 10). In polarized neurons, RNF157 was detectable in axons and dendrites (Figure 10B). Interestingly, RNF157 is restricted to primary dendrites (Figure 10B, lower panel).   
 
Figure 10. RNF157 localizes to the cytoplasm, axons and primary dendrites in neurons. A) Cerebellar granule neurons at DIV 7 were subjected to immunocytochemistry using the RNF157 antibody and the DNA dye  bisbenzimide  (Hoechst  33258).  B)  Hippocampal  neurons  at  DIV  4  were  subjected  to immunocytochemistry using the RNF157, TujI or MAP2 antibodies and the DNA dye bisbenzimide (Hoechst 33258). Asterisks and arrows indicate axons and dendrites, respectively. Scale bar equals 20 µm. 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 Finally,  I  asked  whether  RNF157  is  present  in  dendritic  spines.  I  examined  the subcellular  localization  of  RNF157  in  hippocampal  neurons  at  DIV  21.  Neurons  were immunostained  with  the  RNF157  antibody  and  the  PSD‐95  antibody  as  a  marker  for dendritic  spines.  While  I  found  that  RNF157  is  present  in  the  cytoplasm,  axons  and dendrites of DIV 21 hippocampal neurons, RNF157 is absent from dendritic spines (Figure 11). 
 
Figure 11. RNF157  is  absent  from dendritic  spines. Hippocampal  neurons  at DIV 21 were  subjected  to immunocytochemistry  using  the  RNF157  and  PSD‐95  antibodies.  Nuclei  were  stained  with  the  DNA  dye bisbenzimide (Hoechst 33258). Arrows indicate spines. Scale bar equals 10 µm. 
3.2 Functional analyses of RNF157 in neurons   Sequence  and  domain  analyses  revealed  that  RNF157  and  Mgrn1  share  a  highly conserved N‐terminus and an identical RING domain. In 2003, He and colleagues reported that Mgrn1 knockout mice develop severe age‐dependent spongiform neurodegeneration (He  et  al,  2003).  The  role  of  RNF157  in  the  central  nervous  system  however  remains elusive. To  shed  light  on  the  function of RNF157  in neurons,  I  took  an RNA  interference (RNAi) approach to carry out loss‐of‐function analysis using cerebellar granule as a model system. 







Figure  12.  Efficient  knockdown  of  exogenous  RNF157  by 
RNF157 RNAi II and III. Lysates from HEK 293T cells transfected with  the expression plasmid encoding myc‐RNF157  together with the  control  vector,  RNF157  RNAi  plasmids  II  or  III  were immunoblotted with  the myc antibody. 14‐3‐3ß served as  loading control. 
 
3.2.2 RNF157 is a regulator of neuronal survival in cerebellar granule neurons   To examine the role of RNF157 in neurons, I transfected cerebellar granule neurons at DIV 2 with the control vector, RNF157 RNAi plasmids II or  III  together with a plasmid encoding ß‐galactosidase. Four days later, I examined neurons for any abnormal phenotype as compared  to control‐transfected neurons.  Interestingly,  I  found a dramatic  increase  in cell death in RNF157 RNAi‐transfected neurons. While RNF157 RNAi II triggers a slight but significant increase in cell death, RNF157 RNAi III leads to a striking increase in apoptosis in  cerebellar  granule  neurons  (Figure  13A),  reflecting  the  knockdown  efficiency determined  before.  In  addition,  RNF157  knockdown  neurons  display  hallmarks  of apoptosis  including  pyknotic  nuclei,  fragmented  axons  and  cleaved  caspase‐3 immunoreactivity  (Figure  13B).  These  results  suggest  that  RNF157  promotes  neuronal survival  in vitro.  (In all  further knockdown experiments,  I used  the RNF157 RNAi  III and refer to it as RNF157 RNAi unless stated otherwise)  
 
Figure  13.  Knockdown  of  RNF157  increases  neuronal  apoptosis.  A)  Cerebellar  granule  neurons transfected at DIV 2 with the control vector, RNF157 RNAi plasmids II or III together with a plasmid encoding ß‐galactosidase were subjected to  immunocytochemistry using the ß‐galactosidase (ßGal) antibody and the DNA dye bisbenzimide (Hoechst 33258) four days later. Percentage of apoptosis is presented as mean ± SEM. Knockdown of RNF157  significantly  increases  apoptosis  as  compared  to  control‐transfected neurons  (n=3; ANOVA;  *p<0.05;  ***p<0.001).  A  total  of  1225  neurons  were  analyzed.  B)  Cerebellar  granule  neurons 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transfected  with  the  control  vector  or  RNF157  RNAi  plasmid  III  together  with  a  plasmid  encoding  ß‐galactosidase were subjected to immunocytochemistry at DIV 6 using the ß‐galactosidase (ßGal) and cleaved caspase‐3 antibodies and the DNA dye bisbenzimide (Hoechst 33258). Arrows indicate nuclei of transfected neurons in representative images. In the RNF157 knockdown condition, the nucleus is pyknotic and cleaved caspase‐3 positive. Insets depict nuclei indicated with an arrow. Scale bar equals 20 µm.    Next,  to  demonstrate  that  the  increase  in  apoptosis  is  the  specific  result  of  RNAi‐induced  knockdown  of  RNF157  and  not  an  off‐target  effect,  I  performed  rescue experiments. Thus,  I  generated  an RNF157‐Rescue  (RNF157‐Res)  construct with 6  silent mutations  in  the  RNF157  RNAi  III  targeting  region  to  render  it  resistant  to  knockdown (Figure 14A). Immunoblotting of HEK 293T cell lysates transfected with the RNF157 RNAi plasmid together with wild type RNF157 or RNF157‐Res expression plasmids revealed that the  RNF157  RNAi  efficiently  reduces  RNF157  wild  type  levels,  but  fails  to  knockdown RNF157‐Res  (Figure  14B).  In  subsequent  experiments,  cerebellar  granule  neurons were transfected with  the  control  vectors,  RNF157 RNAi  plasmid with  control  vector,  or  both RNF157  RNAi  plasmid  with  RNF157‐Res  expression  plasmid  together  with  a  plasmid encoding ß‐galactosidase. Here, I found that expression of RNF157‐Res in the background of  RNF157  knockdown  significantly  reduces  apoptosis  of  cerebellar  granule  neurons (Figure 14C). These experiments indicate that the increase of apoptosis upon RNF157 RNAi is the result of a specific knockdown of RNF157. Together, my results identify RNF157 as a regulator of neuronal survival in cerebellar granule neurons in vitro.  
 
Figure 14. RNF157  is  required  for neuronal  survival. A) Schematic  representation of myc‐RNF157‐Res. Silent mutations that render RNF157‐Res resistant to RNAi are indicated in red. B) Lysates of HEK 293T cells transfected with the control vector or RNF157 RNAi plasmid together with a plasmid encoding myc‐RNF157 wild type or myc‐RNF157‐Res were immunoblotted using the myc or 14‐3‐3ß antibodies. The latter served as loading  control.  RNF157  RNAi  induces  the  knockdown  of  myc‐RNF157  wild  type,  but  fails  to  effectively induce knockdown of RNF157‐Res. C) Cerebellar granule neurons were transfected at DIV 2 with the control vectors,  RNF157  RNAi  plasmid with  control  vector,  or  both  RNF157  RNAi  plasmid with myc‐RNF157‐Res expression  plasmid  together  with  a  plasmid  encoding  ß‐galactosidase.  Neurons  were  subjected  to immunocytochemistry using  the ß‐galactosidase antibody and  the DNA dye bisbenzimide  (Hoechst 33258) 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four  days  later.  Percentage  of  apoptosis  is  presented  as  mean  ±  SEM.  While  knockdown  of  RNF157 significantly  increases  apoptosis  (n=4;  ANOVA;  ***p<0.001),  expression  of  RNF157‐Res  significantly decreases apoptosis in the background of RNF157 RNAi (n=4; ANOVA; ***p<0.001). A total of 2171 neurons were analyzed. wt, wild type; aa, amino acid. 
3.2.2.1 Overexpression of RNF157 protects granule neurons from cell death under 
apoptotic stimuli   Having  identified  RNF157  as  a  pro‐survival  factor  in  neurons,  I  asked  if overexpression  of  RNF157  protects  neurons  from  cell  death when  exposed  to  apoptotic stimuli. In addition, to determine if the RING domain of RNF157 and thus E3 ligase activity is  required  for  the  pro‐survival  function  of  RNF157  in  neurons,  I  generated  an  RNF157 mutant that  lacks the RING domain (RNF157 ΔRING). Nicola Schwedhelm‐Domeyer, MPI‐Experimental Medicine, Göttingen carried out gain‐of‐function experiments,  in which  she transfected cerebellar granule neurons at DIV 2 with the control vector, RNF157 wild type or RNF157 ΔRING expression plasmids together with a plasmid encoding ß‐galactosidase. At DIV 5,  conditioned media was replaced with BME 112 starvation media  (= KCl/serum withdrawal)  for 24 hr. Neurons were subsequently  fixed and  immunostained with  the ß‐galactosidase  antibody.  In  control  conditions,  removal  of  conditioned media  leads  to  an increase of the apoptotic rate to 72%. Strikingly, expression of wild type RNF157 reduces the number of apoptotic neurons by 26.4%, while RNF157 ΔRING fails to protect neurons from  cell  death  (Figure  15).  Together,  these  results  suggest  that  RNF157  promotes neuronal survival in an E3 ligase activity‐dependent manner.   
 
Figure  15.  Overexpression  of  RNF157  promotes  neuronal  survival.  Cerebellar  granule  neurons  were transfected  at  DIV  2  with  the  control  vector,  myc‐RNF157  wild  type  or  myc‐RNF157  ΔRING  expression plasmids together with a plasmid encoding ß‐galactosidase. Three days later, neurons were starved for 24 hr and  subjected  to  immunocytochemistry using  the ß‐galactosidase  antibody  and  the DNA dye bisbenzimide (Hoechst 33258). Percentage of apoptosis is presented as mean ± SEM. RNF157 overexpression significantly reduces  apoptosis, while  expression  of  RNF157 ΔRING  fails  to  inhibit  cell  death  in  neurons  (n=4;  ANOVA; *p<0.05; ***p< 0.001). A total of 1383 neurons were analyzed. (Courtesy of N. Schwedhelm‐Domeyer) 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3.2.2.2 RNF157  promotes  neuronal  survival  independently  of  the  neuronal  cell 
type   Next,  I  determined  whether  the  survival‐promoting  function  of  RNF157  is generalizable  in  mammalian  neurons.  Hence,  I  used  cultured  hippocampal  neurons  to analyze the effect of RNF157 loss‐of‐function in hippocampal neuron survival. Rat primary hippocampal neurons were  isolated  from E18 rat embryos and transfected at DIV 2 with the  control  vector  or  RNF157  RNAi  plasmid  together  with  a  plasmid  encoding  ß‐galactosidase.  Neurons  were  subjected  to  survival  assays  at  DIV  6.  Here,  I  found  that knockdown of RNF157 dramatically increases cell death to 98% in hippocampal neurons as compared to control‐transfected neurons (Figure 16). These results implicate that RNF157 regulates neuronal survival in a diverse population of neurons in the brain.  
 
Figure  16.  Knockdown  of  RNF157  dramatically  increases  apoptosis  in  hippocampal  neurons.  A) Hippocampal neurons transfected at DIV 2 with the control vector or RNF157 RNAi plasmid together with a plasmid encoding ß‐galactosidase were subjected to immunocytochemistry using the ß‐galactosidase (ßGal) antibody  and  the  DNA  dye  bisbenzimide  (Hoechst  33258)  four  days  later.  Percentage  of  apoptosis  is presented as mean ± SEM. Apoptosis is significantly increased in RNF157 knockdown neurons as compared to control‐transfected neurons (n=3; Student’s t‐test, ***p<0.001). A total of 655 neurons were analyzed. B) Representative  images  of  neurons  transfected  with  the  control  vector  or  RNF157  RNAi  plasmid.  RNF157 knockdown neurons  show morphological  characteristics  of  apoptosis  (pyknotic  nuclei,  cellular  breakdown leading to formation of apoptotic bodies). Arrows indicate nuclei of transfected neurons. Insets depict nuclei indicated with an arrow. Asterisks indicate apoptotic bodies. Scale bar equals 20 µm. 
3.2.3 RNF157  promotes  dendrite  development  and  maintenance  in  cerebellar 
granule neurons   Recent  literature  has  uncovered  dual  roles  for  several  neurotrophic  factors  in neurons.  One  of  those  is  the  nerve  growth  factor  (NGF)  that  is  required  for  survival  of sympathetic neurons, but also mediates axon outgrowth  in vitro  (Glebova & Ginty, 2004). 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The  latter  was  established  by  deleting  the  pro‐apoptotic  protein  Bax  that  allowed  the analysis of the survival‐independent role of NGF in axon outgrowth. This prompted me to ask  whether  RNF157  could  also  be  involved  in  neuronal  morphogenesis  in  cerebellar granule  neurons.  To  overcome  RNF157  RNAi‐induced  apoptosis  in  neurons,  I  took advantage of the pro‐survival Bcl‐2 family member Bcl‐xL to perform morphological assays. 
3.2.3.1 Knockdown of RNF157 reduces dendritic but not axonal length in cerebellar 




Figure 17. Knockdown of RNF157 impairs dendrite development but has no effect on axon growth. A) Cerebellar  granule  neurons  transfected  at  DIV  4  with  the  control  vector,  RNF157  RNAi  plasmids  II  or  III together with the Bcl‐xL and GFP expression plasmids were subjected to immunocytochemistry using the GFP antibody and the DNA dye bisbenzimide (Hoechst 33258) four days  later. Axonal and total dendritic  length were measured and presented as mean ± SEM. Knockdown of RNF157 has little or no effect on axonal length in  cerebellar  granule  neurons  (n.s.,  not  significant).  B)  Total  dendritic  length  is  significantly  reduced  in RNF157 knockdown neurons  transfected with  the RNF157 RNAi plasmids  II or  III  as  compared  to control‐transfected  neurons  (n=5;  ANOVA;  ***p<0.001).  A  total  amount  of  653  neurons  were  analyzed.  C) Representative  images  of  neurons  transfected  with  the  control  vector,  RNF157  RNAi  plasmids  II  or  III. Asterisks and arrows indicate axons and dendrites, respectively. Scale bar equals 20 µm.   
 
Figure 18. RNF157 is required for dendrite growth in neurons. A) Cerebellar granule neurons transfected at DIV 4 with the control vectors, RNF157 RNAi plasmid with control vector, or both RNF157 RNAi plasmid with  myc‐RNF157‐Res  expression  plasmid  together  with  the  Bcl‐xL  and  GFP  expression  plasmids  were 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subjected  to  immunocytochemistry  using  the  GFP  antibody  four  days  later.  Expression  of  RNF157‐Res  in RNF157 knockdown neurons significantly restores total dendritic length as compared to control‐transfected neurons  (n=3;  ANOVA;  ***p<0.001).  A  total  of  322  neurons  were  analyzed.  B)  Representative  images  of neurons  transfected with  the  control  vectors,  RNF157  RNAi  plasmid with  control  vector,  or  both  RNF157 RNAi  plasmid  with  RNF157‐Res  expression  plasmid.  Asterisks  and  arrows  indicate  axons  and  dendrites, respectively. Scale bar equals 20 µm.  
3.2.3.2 Knockdown of  RNF157  reduces  dendrite  complexity  in  cerebellar  granule 
neurons   To  further characterize  the dendritic phenotype of  the RNF157 RNAi,  I performed Scholl analysis to determine the complexity of RNF157 knockdown neurons. Here, ImageJ software automatically counts the number of dendrites crossing concentric circles placed around the soma of a neuron at 7.5 μm increments. At a radius of 22.5 μm to 75 µm from the cell body, RNF157 knockdown neurons show a significant reduction in the total amount of crossing dendrites as compared to control‐transfected neurons (Figure 19). This analysis supports the role of RNF157 in dendrite growth and development.  
 
Figure 19. Knockdown of RNF157 reduces dendrite complexity. Cerebellar granule neurons transfected at  DIV  4  with  the  control  vector  or  RNF157  RNAi  plasmid  together  with  the  Bcl‐xL  and  GFP  expression plasmids  were  subjected  to  immunocytochemistry  using  the  GFP  antibody  four  days  later.  Dendrite complexity was assessed by Scholl analysis and presented as mean ± SEM. The numbers of crossing dendrites from  22,5  to  75  µm  around  the  cell  soma  are  significantly  reduced  in  RNF157  knockdown  neurons  as compared  to  control‐transfected neurons  (n=3,  Student’s  t‐test; 22,5 µm *p<0.05; 30 µm *p<0.05; 37,5 µm *p<0.05; 45 µm **p<0.01; 52,5 µm *p<0.05; 60 µm *p<0.05; 67,5 µm **p<0.01; 75 µm *p<0.05). A total of 89 neurons were analyzed. 
3.2.3.3 RNF157  is  important  for  the  maintenance  of  cerebellar  granule  neuron 
dendrites   In  further  experiments,  I  addressed  if  RNF157  is  crucial  for  the  maintenance  of dendrites after they have formed. To answer this, I transfected cerebellar granule neurons at DIV 4 with the control vector, RNF157 RNAi plasmids II or  III  together with the Bcl‐xL and  GFP  expression  plasmids  and  started  measuring  total  dendritic  length  24  hr  after 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transfection over a period of four consecutive days. At DIV 5, control neurons displayed a characteristic  dendritic  arborization  that  did  not  undergo  further  growth  until  DIV  8. Neurons  transfected  with  the  RNF157  RNAi  plasmids  II  or  III  displayed  dendritic morphology comparable to control‐transfected neurons at DIV 5. However, while RNF157 RNAi plasmid II‐transfected neurons still exhibit stable dendritic length at DIV 6, dendrites of RNF157 RNAi plasmid III‐transfected neurons are significantly shorter. At DIV 7 and 8, dendrites of both RNF157 RNAi plasmids  II and  III‐transfected neurons undergo striking shrinkage  in  comparison  to  control‐transfected  neurons  (Figure  20).  Given  that  the RNF157 RNAi III reduces RNF157 levels more efficiently as compared to the RNF157 RNAi II,  the  results also suggest a dose‐dependent  response of dendrites  to  loss‐of‐RNF157.  In summary, my results indicate that RNF157 is important for the maintenance of dendrites in cerebellar granule neurons.  
 
Figure  20.  RNF157  is  important  for  the  maintenance  of  dendrites.  Cerebellar  granule  neurons  were transfected at DIV 4 with the control vector, RNF157 RNAi plasmids II or III together with the Bcl‐xL and GFP expression plasmids. Neurons were fixed on the indicated days and subjected to immunocytochemistry using the GFP antibody. Total dendritic length was measured and presented as mean ± SEM. The RNF157 RNAi II significantly  decreases  total  dendritic  length  on  DIV  7  and  8,  while  the  RNF157  RNAi  III  significantly decreases  dendritic  length  on DIV  6  and  subsequent  days  as  compared  to  control‐transfected  neurons  (at least n=3; ANOVA; ***p<0.001). A total of 1550 neurons were analyzed. 
3.2.3.4 Introduction of  the Wallerian degeneration slow fusion protein (Wlds) has 
no effect on the RNF157­knockdown induced dendritic phenotype   Wlds  was  originally  identified  in  the  slow Wallerian  degeneration mutant  mouse, where it significantly delays injury‐induced axonal degeneration as compared to wild type mice (Lunn et al, 1989). Wallerian degeneration slow fusion protein (Wlds) is a product of the  rearrangement  of  two  independent  genes,  which  encode  an  in‐frame  fusion  protein (Coleman et al, 1998) (Conforti et al, 2000). The N‐terminus of Wlds is derived from the N‐terminus  of  the  E4‐type  ubiquitin  ligase  Ube4b,  whereas  the  C‐terminus  displays  the 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complete  coding  region of  the nicotinamide mononucleotide adenyltransferase 1  (Nmnat 1),  which  are  connected  by  an  18  aa  linker  (Coleman  et  al,  1998)  (Mack  et  al,  2001). However, recent data suggests that expression of the Wlds in dorsal dendritic arborization neurons  (ddaC)  inhibits dendrite pruning as well  as dendrite degeneration  (Tao & Rolls, 2011). In this study, I investigated whether overexpression of Wlds can block the reduction of cerebellar granule neuron dendrite length induced by knockdown of RNF157.    Thus,  I  transfected  cerebellar  granule  neurons  at  DIV  4  with  the  control  vectors, Wlds expression plasmid with control vector, RNF157 RNAi plasmid with control vector, or both RNF157 RNAi plasmid with Wlds expression plasmid together with the Bcl‐xL and GFP expression plasmids. At DIV 8, morphological analysis revealed that overexpression of Wlds has little or no effect on cerebellar granule neuron dendrite length as compared to control‐transfected neurons. In addition, expression of Wlds in RNF157 knockdown neurons does not  restore  the  RNF157  RNAi‐induced  reduction  in  total  dendritic  length  (Figure  21). These results suggest that Wlds does not operate downstream of RNF157 in the regulation of granule neuron dendrite growth.  
 
 




3.2.3.5 RNF157  significantly  increases  dendritic  but  not  axonal  length  in  an  E3 
ligase activity­independent manner in cerebellar granule neurons   Having established that RNF157 promotes dendrite morphogenesis and complexity, I  asked  whether  overexpression  of  RNF157  would  trigger  a  gain‐of‐function  effect  in dendrite development. In addition, I addressed whether a potential gain‐of‐function effect is  dependent  on  RNF157´s  E3  ligase  activity.  To  answer  this  question,  I  transfected cerebellar granule neurons at DIV 4 with the control vector, RNF157 wild type or RNF157 ΔRING  expression  plasmids  together  with  the  Bcl‐xL  and  GFP  expression  plasmids  and analyzed dendrite morphology at DIV 8.   
 
Figure  22.  Overexpression  of  RNF157  increases  dendritic  but  not  axonal  length  in  an  E3  ligase 
activity­independent  manner.  Cerebellar  granule  neurons  transfected  at  DIV  4  with  the  control  vector, myc‐RNF157  wild  type  or  myc‐RNF157  ΔRING  expression  plasmids  together  with  the  Bcl‐xL  and  GFP expression plasmids were subjected to immunocytochemistry using the GFP antibody four days later. Axonal and total dendritic length were measured and presented as mean ± SEM. A) Overexpression of RNF157 and RNF157  ΔRING  significantly  increases  total  dendritic  length  as  compared  to  control‐transfected  neurons (n=3;  ANOVA;  ***p<0.001;  n.s.,  not  significant).  A  total  of  315  neurons  were  analyzed.  B)  Representative images of control, myc‐RNF157 and myc‐RNF157 ΔRING transfected neurons. Asterisks and arrows indicate axons and dendrites, respectively. Scale bar equals 20 µm. C) Overexpression of RNF157 has little or no effect on axonal length (n.s.; not significant). A total of 267 neurons were analyzed. 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Morphological  analysis  revealed  that  overexpression  of  RNF157  and  RNF157  ΔRING significantly increases dendritic length as compared to control‐transfected neurons (Figure 22A/B).  Furthermore,  overexpression  of  RNF157  has  little  or  no  effect  on  axonal  length (Figure  22C).  These  results  indicate  that  RNF157  selectively  promotes  dendritic  but  not axonal morphogenesis in an E3 ligase activity‐independent manner. 
3.2.3.6 Overexpression of RNF157 influences dendritic arborization   In addition to the RNF157 overexpression‐induced increase in total dendritic length, I noticed a more elaborate dendritic tree. To confirm this observation, I performed Scholl analysis.  At  a  radius  of  45  μm  to  85.5  µm  from  the  cell  body,  RNF157  overexpressing neurons show a significant increase in the total amount of crossing dendrites as compared to  control‐transfected  neurons  (Figure  23).  These  results  suggest  that  in  addition  to dendrite growth regulation and maintenance, RNF157 affects the complexity of cerebellar granule neuron dendrites. 
 
Figure  23.  Overexpression  of  RNF157  increases  dendrite  complexity.  Cerebellar  granule  neurons transfected  at  DIV  4  with  the  control  vector  or  RNF157  RNAi  plasmid  together  with  the  Bcl‐xL  and  GFP expression  plasmids  were  subjected  to  immunocytochemistry  using  the  GFP  antibody  four  days  later. Dendrite complexity was assessed by Scholl analysis and presented as mean ± SEM. The numbers of crossing dendrites  from  45  to  85,5  µm  around  the  cell  soma  are  significantly  increased  in  RNF157‐overexpressing neurons  as  compared  to  control‐transfected  neurons  (n=3,  Student’s  t‐test;  45  µm  ***p<0.001;  52,5  µm *p<0.05; 60 µm **p<0.01; 67,5 µm **p<0.01; 75 µm *p<0.05; 82,5 µm *p<0.05). A total of 84 neurons were analyzed. 
3.2.3.7 RNF157 promotes dendrite development independently of the neuronal cell 
type   To establish whether RNF157‐regulated dendrite morphogenesis is a generalizable mechanism, I determined whether the RNF157‐knockdown induced dendritic phenotype is true  for other neuronal cell  types. Here,  I used cultured hippocampal neurons  to analyze the  influence  of  RNF157  knockdown  on  dendritic  as well  as  on  axonal morphology.  Rat 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primary hippocampal neurons were  isolated  from E18 embryos and  transfected at DIV 4 with  a  bicistronic  control  vector  or  RNF157  RNAi  plasmid  additionally  expressing  GFP under  the  control  of  a  CMV  promoter.  Hippocampal  neurons  were  subjected  to morphological analysis at DIV 8. While  the RNF157 RNAi has  little or no effect on axonal length (Figure 24A), these neurons exhibit a striking reduction in dendritic length. RNF157 knockdown  neuron  dendrites  are  85%  shorter  than  control‐transfected  neurons  (Figure 24B/C).  These  results  identify  RNF157  as  a  regulator  of  dendrite  morphogenesis independently of the neuronal cell type.  
  
Figure  24.  Knockdown  of  RNF157  dramatically  decreases  dendritic  but  not  axonal  length  in 
hippocampal  neurons. Hippocampal  neurons  transfected  at  DIV  4  with  the  bicistronic  control  vector  or RNF157  RNAi  plasmid  together  with  a  plasmid  encoding  Bcl‐xL  were  subjected  to  immunocytochemistry using  the GFP antibody  four days  later. Axonal and  total dendritic  length were measured and presented as mean ± SEM. A) Knockdown of RNF157 has little or no effect on axonal length in hippocampal neurons (n.s., not  significant).  B)  Total  dendritic  length  is  significantly  reduced  in  RNF157  knockdown  neurons  as compared to control‐transfected neurons (n=3; Student’s t‐test; ***p<0.001). A total amount of 189 neurons were  analyzed.  C)  Representative  images  of  hippocampal  neurons  transfected with  the  bicistronic  control vector or RNF157 RNAi plasmid. Asterisks and arrows indicate axons and dendrites, respectively. Scale bar equals 20 µm. 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3.3 Identification  of  RNF157  interacting  proteins  in  the  mammalian 
brain  




the control of neuronal survival   Among  the novel  identified RNF157  interactors,  I decided  to  focus on  the adapter protein  Fe65.  Fe65,  which  is  a  member  of  a  small  family  the  multimodular  scaffolding proteins including Fe65L1 and Fe65L2, is enriched in the brain (Bressler et al, 1996; Duilio et al, 1991). In neurons, Fe65 is present in the cytoplasm and the nucleus (Hoe et al, 2006). Together with Mena (a regulator of actin dynamics) and amyloid precursor protein (APP), Fe65  forms  a  trimeric  complex  and  influences  cell  motility,  axon  branching  and  growth cone formation (Ermekova et al, 1997; Ikin et al, 2007; Sabo et al, 2001; Sabo et al, 2003). Furthermore,  Fe65  plays  an  important  role  in  DNA  repair  with  APP  and  the  histone acetyltransferase Tip60 (Stante et al, 2009). On this basis, Fe65 emerged as an interesting candidate and  I  addressed whether Fe65 could be a possible  substrate of RNF157 and  if they act in concert to control dendrite development or neuronal survival. 




Figure 25. Fe65 interacts with RNF157 in heterologous cells and in vivo. A/B) Lysates of HEK 293T cells transfected with Flag‐Fe65 or myc‐RNF157 together with control vector, or both Flag‐Fe65 and myc‐RNF157 were  immunoprecipitated  using  the  Fe65  or RNF157  antibodies  respectively  and  immunoblotted with  the indicated antibodies. C/D) Crude lysates of P6 rat cerebellum or P12 mouse cortex were immunoprecipitated with a preimmune serum (PIS) or the Fe65 antibody followed by immunoblotting with the RNF157 antibody (Courtesy of A. Holubowska). Asterisk, IgGH; IB, immunoblot; IP, immunoprecipitation. 
3.4.1.1 Mapping the specific binding regions of RNF157 and Fe65   To map the regions of Fe65 and RNF157 that are required for their interaction, Dr. Judith Stegmüller, MPI of Experimental Medicine, Göttingen, cloned truncation mutants of RNF157  and  Fe65.  Co‐immunoprecipitation  experiments  to  identify  the  RNF157  binding region in Fe65 were performed by Shih‐Ju Lee, those to identify the Fe65 binding region in RNF157  by  Nicola  Schwedhelm‐Domeyer.  RNF157  interacts  with  Fe65  fragments  that harbor  the  second PTB domain  (Fe65aa525‐711  as well  as  to  Fe65aa325‐711).  In  addition,  the binding of RNF157 with Fe65aa325‐711 seemed to be stronger than with Fe65aa525‐711 (Figure 26A). Conversely, Fe65 interacts with RNF157aa1‐237 and RNF157aa238‐442 suggesting that the Fe65 binding region was divided into two parts (Figure 26B). Furthermore, Fe65 interacts 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with RNF157  in an RING‐domain  independent manner (Figure 26B). Hence,  these results indicate that the Fe65 binding region is located N‐terminally in front of the RING domain, while the C‐terminal fragment with 2nd PTB domain of Fe65 binds to RNF157 (Figure 26C).  
  
Figure  26.  Mapping  the  interacting  regions  of  RNF157  and  Fe65.  A/B)  Lysates  of  HEK  293T  cells transfected  with  the  indicated  plasmids  were  immunoprecipitated  using  the  myc  antibody  followed  by immunoblotting with the GFP antibody. (A= courtesy of S.J. Lee; B= courtesy of N. Schwedhelm‐Domeyer). C) Schematic  representation  of  the  interaction  domains  of  RNF157  and  Fe65.  IB,  immunoblot;  IP, immunoprecipitation. Asterisks indicate positive interactions. 
3.4.2 Expression and localization of Fe65 during brain development   The  expression  of  Fe65  was  examined  in  cultured  primary  neurons  and  in  the developing  brain.  I  examined  the  expression  of  Fe65  in  rat  primary  cerebellar  neurons isolated from P6 rat pups and in primary cortical neurons prepared from E18 rat embryos. Western  blot  analysis  revealed  a  strong  expression  of  Fe65  from  DIV  2‐6  in  cerebellar granule neurons, whereas cortical neurons display a weaker expression (Figure 27A). Next, I  analyzed  the  expression  of  Fe65  in  tissue  lysates  of  mouse  cerebellum,  cortex  and hippocampus  isolated at different ages.  In  the cerebellum,  I observed Fe65 expression as early as E18 with an increase of expression at later postnatal ages (P9‐14) and the highest 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expression  level  in  adulthood.  While  Fe65  expression  in  cortex  is  weaker  and  mostly unchanged throughout development, Fe65 expression in hippocampus is highest at E18‐P0 with a subsequent decrease of expression at older stages (Figure 27B).  
  
Figure 27. Developmental expression of Fe65 in the brain. A) Lysates of cerebellar granule and cortical neurons  prepared  from  P6  or  E18  rats  respectively  and  placed  in  culture  for  the  indicated  days  were immunoblotted using the Fe65 and 14‐3‐3ß antibodies. The latter served as loading control. B) Crude lysates of mouse cerebellum, cortex and hippocampus isolated at the indicated days (E, embryonic; P, postnatal day) were subjected to immunoblotting using the Fe65 antibody. 14‐3‐3ß served as loading control.    To examine the subcellular localization of Fe65, I subjected DIV 6 cerebellar granule neurons  to  immunocytochemistry  using  the  Fe65  antibody.  Intracellular  localization  of Fe65  was  detected  in  the  cytoplasm  of  cell  bodies,  the  processes  and  in  the  nucleus  of cerebellar  granule  neurons  (Figure  28).  In  summary,  I  found  that  Fe65  is  expressed throughout  development  and  localizes  to  the  cytoplasm,  processes  and  the  nucleus  in neurons.  
 




antibody  and  the  DNA  dye  bisbenzimide  (Hoechst  33258).  Arrows  and  asterisks  indicate  processes  and nuclei, respectively. Scale bar equals 20 µm.  
3.4.3 Ubiquitination of Fe65 in cerebellar granule neurons    Given that Fe65 interacts with RNF157, I asked whether Fe65 is ubiquitinated and degraded  via  the  ubiquitin‐proteasome  system  in  neurons.  Hence,  cerebellar  granule neurons  were  treated  at  DIV  2  with  vehicle  or  lactacystin  (selective  inhibitor  of  the proteasome) and Fe65 expression was assessed  in Western blot experiments. Here, Fe65 protein levels were increased upon proteasome inhibition (Figure 29A). Next, we examined if Fe65  is ubiquitinated  in  the rodent brain and how the ubiquitin moieties are  linked  to Fe65. Dr. Judith Stegmüller, MPI of experimental Medicine, Göttingen subjected cerebellar granule neurons at DIV 7 to immunoprecipitation using either the control (HA antibody) or Fe65 antibodies. Immunoblotting with an ubiquitin specific antibody revealed that Fe65 is indeed polyubiquitinated in neurons (Figure 29B).  
 
Figure 29. Ubiquitination of Fe65  in neurons. A) Lysates of  cerebellar granule neurons at DIV 2  treated with  20  µm  lactacystin  or  vehicle  for  5  hr were  subjected  to  immunoblotting  using  the  Fe65  and  14‐3‐3ß antibodies. The  latter  served as  loading  control. B) Cerebellar  granule neurons  at DIV 7 were  subjected  to immunoprecipitation  using  the  HA  (control)  or  Fe65  antibodies  followed  by  immunoblotting  with  an ubiquitin  antibody  (Courtesy  of  J.  Stegmüller).  C)  Cerebellar  granule  neurons  at  DIV  6  were  subjected  to immunoprecipitation  using  the  GFP  (control)  or  Fe65  antibodies  followed  by  immunoblotting  using  the Lys48‐or Lys63‐specific ubiquitin antibodies. IB, immunoblot; IP, immunoprecipitation. Arrowheads indicate Fe65.    In further experiments, I examined the nature of the polyubiquitin chains linked to Fe65. Ubiquitin harbors seven different lysine residues (Lys 6, 11, 27, 29, 33, 48 and 63) by which it can be conjugated to the target substrate or to another ubiquitin molecule (Goto et al, 2010) (Peng et al, 2003). While polyubiquitin chains linked via Lys48 target proteins for proteasomal  degradation,  Lys63‐linked  ubiquitin  chains  mediate  functional  protein modifications  (Bennett  et  al,  2007).  To  analyze  if  Fe65  is  targeted  for  proteasomal 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degradation  or  ubiquitinated  in  a  non‐degradative  manner,  I  used  antibodies  that specifically  recognize  either  Lys48‐or  Lys63‐linked  ubiquitin  chains.  Thus,  cerebellar granule neurons were subjected at DIV 6 to immunoprecipitation using the control GFP or Fe65 antibodies. Both, immunoblotting with Lys48‐and Lys63‐ubiquitin specific antibodies produced  a  polyubiquitination  smear  (Figure  29C).  These  results  suggest  that  Fe65  is modified by the attachment of Lys48‐and Lys63‐linked polyubiquitin chains. In summary, we  could  show  that  Fe65  is  ubiquitinated  and  degraded  in  a  proteasome‐dependent manner  and  undergoes  non‐degradative  ubiquitin  modification  that  may  alter  its localization, activity or interaction with binding partners (Schnell & Hicke, 2003).  
3.4.4 Fe65 is ubiquitinated by RNF157   Next, we  set  out  to  investigate  if  RNF157  exhibits  autoubiquitination  activity  and subsequently  if  Fe65  may  serve  as  a  novel  target  of  RNF157.  These  experiments  were carried out by Nicola Schwedhelm‐Domeyer. To analyze whether RNF157 would catalyze ubiquitination,  in  vitro  ubiquitination  assays  were  performed.  Myc‐RNF157  was immunopurified  from Neuro 2A cells and  incubated  in  the presence of ATP, E1, different E2s  and  ubiquitin.  Immunoblotting  of  the  reaction  products  with  an  ubiquitin  antibody revealed  that  RNF157  in  a  complex  with  the  E2  UbcH5a  exhibits  a  polyubiquitination smear (Figure 30A). This result suggests that RNF157 harbors autoubiquitination activity 




Figure  30.  RNF157  ubiquitinates  Fe65  in  vitro.  A)  Enzymatic  activity  of  RNF157.  Myc‐RNF157  was immunoprecipitated from Neuro 2A cells and subjected to in vitro ubiquitination in the presence of ATP, E1, different  E2s  (UbcH3, UbcH5a, UbcH5b,  or UbcH5c)  and  ubiquitin.  Ubiquitinated RNF157 was  detected  by immunoblotting with an ubiquitin antibody (courtesy of N. Schwedhelm‐Domeyer). B) Immunopurified Flag‐Fe65 (as described in Materials and Methods) was subjected to in vitro ubiquitination in the presence of ATP, E1, different E2s (UbcH2, UbcH3, UbcH5a, UbcH5b, or UbcH5c), ubiquitin and immunopurified myc‐RNF157 as  indicated. Modified Fe65 was detected by  immunoblotting using  the Flag antibody,  to avoid detection of autoubiquitinated RNF157 (courtesy of N. Schwedhelm‐Domeyer). IB, immunoblot; IP, immunoprecipitation; Ub, ubiquitin. Arrow indicates Ub‐Fe65. 
3.4.5 Knockdown of  Fe65 has  no  effect  on dendrite  growth  in  cerebellar  granule 
neurons   RNF157 regulates dendrite growth and neuronal survival. This raises the question whether  Fe65  plays  a  role  in  dendrite  development.  To  carry  out  Fe65  loss‐of‐function analysis,  I  generated  Fe65  RNAi  plasmids  that  target  human,  mouse  and  rat  Fe65.  The knockdown efficacy of the three different Fe65 RNAi plasmids was tested in heterologous cells. I transfected HEK 293T cells with control vector or the different Fe65 RNAi plasmids together with a plasmid encoding Fe65 and subjected these lysates to immunoblotting four days later. While the Fe65 RNAi plasmid II shows a slight reduction in Fe65 protein level, Fe65  RNAi  III  exhibits  the most  efficient  knockdown  of  Fe65  in  HEK  293T  cells  (Figure 31A). Hence, in all further knockdown experiments, I used the Fe65 RNAi III and referred to it as Fe65 RNAi unless stated otherwise. Next, I transfected cerebellar granule neurons at DIV 4 with  the control vector or Fe65 RNAi plasmid  together with  the Bcl‐xL and GFP expression plasmids and subjected these neurons to immunocytochemistry at DIV 8 using the GFP antibody. Morphological analysis revealed that knockdown of Fe65 has little or no effect on total dendritic length as compared to control‐transfected neurons (Figure 31B/C). 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These  results  suggest  that  Fe65  is  not  involved  in  the  regulation  of  dendrite morphogenesis.   
 
Figure 31. Knockdown of Fe65 has no effect on dendrite morphogenesis. A) Lysates from HEK 293T cells transfected  with  the  expression  plasmid  encoding  myc‐Fe65  together  with  control  vector  or  Fe65  RNAi plasmids I, II or III were immunoblotted with the myc antibody. 14‐3‐3ß served as loading control. Asterisk indicates functional Fe65 RNAi. B) Cerebellar granule neurons transfected at DIV 4 with the control vector or Fe65  RNAi  plasmid  together  with  the  Bcl‐xL  and  GFP  expression  plasmids  were  subjected  to immunocytochemistry using the GFP antibody four days later. Knockdown of Fe65 has little or no effect on dendrite  growth  as  compared  to  control‐transfected  neurons  (n.s,  not  significant).  A  total  of  217  neurons were  analyzed.  C)  Representative  images  of  neurons  transfected  with  the  control  vector  or  Fe65  RNAi plasmid. Asterisks and arrows indicate axons and dendrites, respectively. Scale bar equals 20 µm. 




Figure 32. Overexpression of  Fe65  induces  apoptosis. Cerebellar  granule  neurons  transfected  at DIV  2 with  the  control vector or myc‐Fe65 expression plasmid  together with a plasmid encoding ß‐galactosidase were subjected to immunocytochemistry using the ß‐galactosidase antibody and the DNA dye bisbenzimide (Hoechst  33258)  four  days  later.  Percentage  of  apoptosis  is  presented  as mean  ±  SEM.  Overexpression  of Fe65  significantly  increases  apoptosis  as  compared  to  control‐transfected  neurons  (n=3;  ANOVA;  ***p< 0.001). A total of 1037 neurons were analyzed.    To  examine  if  the  localization  of  Fe65  is  important  to  its  function  in  neuronal survival,  Fe65 was  targeted  to  the nucleus or  the  cytoplasm. For  this purpose, Dr.  Judith Stegmüller  fused  a  nuclear  exclusion  sequence  (NES)  or  a  nuclear  localization  sequence (NLS) to the N‐terminus of pCMV‐Fe65. The proper localization of NES‐Fe65 and NLS‐Fe65 was  confirmed  in  HEK  293T  cells  as  well  as  in  cerebellar  granule  neurons.  NES‐Fe65 remains in the cytoplasm whereas NLS‐Fe65 localizes to the nucleus (Figure 33A/B). Next, I  analyzed  the  capability  of  the  different  Fe65  mutants  to  induce  neuronal  apoptosis.  I transfected cerebellar granule at DIV 2 with the control vector, wild type Fe65, NES‐Fe65 or NLS‐Fe65  expression  plasmids  together with  a  plasmid  encoding  ß‐galactosidase  and subjected these neurons to survival assays four days later. I found that both wild type Fe65 and the NLS‐Fe65 mutant trigger apoptosis in cerebellar granule neurons. In contrast, NES‐Fe65, sequestered to the cytoplasm, fails to induce neuronal apoptosis (Figure 33C).    To  further  elucidate  the  mechanism  of  Fe65‐induced  neuronal  apoptosis,  I performed  structure‐function  analysis  of  Fe65  in  cerebellar  granule  neurons.  First,  I transfected HEK 293T cells and cerebellar granule neurons with plasmids encoding Fe65 wild  type  or  different  Fe65  truncation  mutants:  Fe65aa1‐325  (WW  domain),  Fe65aa326‐524 (PTB1 domain), Fe65aa525‐711 (PTB2 domain), Fe65aa1‐524 (WW+ PTB1 domain) or Fe65aa326‐711 (PTB1/2 domain) and determined the subcellular localization of these mutants. I found that  wild  type  Fe65  as  well  as  Fe65aa1‐325,  Fe65aa326‐524,  Fe65aa1‐524  and  Fe65aa326‐711  are equally  distributed  between  the  cytoplasm  and  the  nucleus.  Interestingly,  Fe65aa525‐711 (PTB2 domain) is exclusively present in the nucleus in both HEK 293T cells and cerebellar granule neurons (Figure 34A/B). 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 Next,  I  quantified  apoptosis  in  neurons  expressing  the  aforementioned  Fe65 truncation mutants at DIV 6. My results revealed that aside from wild type Fe65, Fe65 aa525‐711 dramatically increases cell death in granule neurons. Fe65aa1‐325, Fe65aa326‐524, Fe65aa1‐524 and Fe65aa326‐711 only show a moderate induction of cell death (Figure 34C). These findings are  consistent with my  results, which  show  that  Fe65  operates  in  the  nucleus  to  induce neuronal  apoptosis.  Moreover,  my  data  indicates  that  the  C‐terminal  region  of  Fe65 (aa525‐711) harbors a nuclear localization signal.  
 
 




Figure 34. Fe65aa525­711 (PTB2) translocates to the nucleus to initiate apoptosis. A/B) HEK 293T cells (A) and cerebellar granule neurons (B) transfected with the myc‐Fe65 wild type, myc‐Fe65aa1‐325 (WW domain), myc‐Fe65aa326‐524 (PTB1 domain), myc‐Fe65aa525‐711 (PTB2 domain), myc‐Fe65aa1‐524 (WW+ PTB1 domain) or myc‐Fe65aa326‐711 (PTB1/2 domain) expression plasmids were subjected to  immunocytochemistry using the myc  antibody  and  the  DNA  dye  bisbenzimide  (Hoechst  33258).  Arrows  and  asterisks  indicate cytoplasmic/axonal/dendritic  or  nuclear  localizations,  respectively.  Scale  bar  equals  20  µm.  C)  (Left) Cerebellar  granule  neurons  transfected  at  DIV  2  with  the  control  vector,  myc‐Fe65,  myc‐Fe65aa1‐325  (WW domain),  myc‐Fe65aa326‐524  (PTB1  domain),  myc‐Fe65aa525‐711  (PTB2  domain),  myc‐Fe65aa1‐524  (WW+PTB1 domain)  or  myc‐Fe65aa326‐711  (PTB1/2  domain)  expression  plasmids  together  with  a  plasmid  encoding  ß‐galactosidase were subjected to immunocytochemistry using the ß‐galactosidase antibody and the DNA dye bisbenzimide  (Hoechst  33258)  four  days  later.  Percentage  of  apoptosis  is  presented  as  mean  ±  SEM. 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Overexpression of Fe65aa525‐711 dramatically increases apoptosis as compared to control‐transfected neurons (n=3;  ANOVA;  *p<0.05;  **p<0.01;  ***p<0.001).  A  total  of  3203  neurons  were  analyzed.  (Right)  Color  of mutants match columns in survival assay. 
3.4.7 Knockdown  of  Fe65  reduces  starvation­induced  apoptosis  in  cerebellar 
granule neurons   Given that Fe65 acts as a pro‐apoptotic protein, I reasoned that knockdown of Fe65 under apoptotic stimuli may attenuate neuronal cell death. Hence, I transfected cerebellar granule  neurons  at DIV 2 with  the  control  vector  or  Fe65 RNAi plasmid  together with  a plasmid encoding ß‐galactosidase. At DIV 5, conditioned media was replaced with BME 112 starvation media  (= KCl/serum withdrawal)  for  18 hr. Neurons were  subsequently  fixed and  immunostained with  the ß‐galactosidase antibody. As expected, starvation  leads  to a high rate of apoptosis  in control neurons. Strikingly, apoptosis  is significantly reduced by 50%  in  Fe65  RNAi‐transfected  neurons  (Figure  35).  These  results  suggest  that  Fe65 promotes apoptosis in cerebellar granule neurons.  
 
Figure  35.  Knockdown  of  Fe65  reduces  starvation­induced  apoptosis. A)  Cerebellar  granule  neurons were transfected at DIV 2 with the control vector or Fe65 RNAi plasmid together with a plasmid encoding ß‐galactosidase. Three days later, neurons were starved in KCl and serum‐free media for 18 hr and subjected to immunocytochemistry  using  the  ß‐galactosidase  (ßGal)  antibody  and  the  DNA  dye  bisbenzimide  (Hoechst 33258).  Percentage  of  apoptosis  is  presented  as mean  ±  SEM.  Knockdown  of  Fe65  significantly  decreases apoptosis  as  compared  to  control‐transfected  neurons  (n=4;  Student’s  t‐test;  ***p<0.001).  A  total  of  2476 neurons were  analyzed.  B)  Representative  images  of  neurons  transfected with  the  control  vector  or  Fe65 RNAi  plasmid.  Arrows,  arrowheads  and  asterisks  indicate  nuclei,  soma  or  apoptotic  bodies  of  transfected neurons, respectively. Insets depict nuclei indicated with an arrow. Scale bar equals 20 µm. 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3.4.8 RNF157  knockdown­induced  increase  in  neuronal  apoptosis  can  be 




Figure 36. RNF157 acts  in a  linear pathway with DR6  in  the control of neuronal survival. A) Lysates from HEK 293T  cells  transfected with  a  plasmid  encoding myc‐DR6  together with  the  control  vector, DR6 RNAi  plasmids  I,  II  or  III  were  immunoblotted with  the myc  antibody.  14‐3‐3ß  served  as  loading  control. Asterisk indicates functional DR6 RNAi. B) Cerebellar granule neurons transfected at DIV 2 with the control vectors, RNF157 RNAi plasmid with control vector, DR6 RNAi III plasmid with control vector, or both RNF157 and  DR6  RNAi  III  plasmids  together  with  a  plasmid  encoding  ß‐galactosidase  were  subjected  to immunocytochemistry using  the ß‐galactosidase antibody and  the DNA dye bisbenzimide  (Hoechst 33258) four days  later. Percentage of apoptosis  is presented as mean ± SEM. Knockdown of both RNF157 and DR6 significantly  decreases  apoptosis  as  compared  to  RNF157  RNAi‐transfected  neurons  (n=3;  ANOVA; ***p<0.001). A total of 2502 neurons were analyzed. 
3.4.9 Fe65  acts  downstream  of  RNF157  in  a  linear  pathway  in  the  control  of 




Figure  37.  Fe65  acts  downstream  of  RNF157  in  the  control  of  neuronal  survival. Cerebellar  granule neurons  transfected  at  DIV  2  with  the  control  vector,  RNF157  RNAi  plasmid with  control  vector,  or  both RNF157  and  Fe65  RNAi  plasmids  together  with  a  plasmid  encoding  ß‐galactosidase  were  subjected  to immunocytochemistry using  the ß‐galactosidase antibody and  the DNA dye bisbenzimide  (Hoechst 33258) four days later. Percentage of apoptosis is presented as mean ± SEM. Knockdown of both RNF157 and Fe65 significantly decreases apoptosis as compared to RNF157 RNAi‐transfected neurons (n=3; ANOVA; **p<0.01;  ***p<0.001). A total of 1765 neurons were analyzed. 
3.5 Characterization of a mouse model lacking RNF157 function 
3.5.1 Generation of RNF157 gene trap mice   In  order  to  understand  the  role  of  RNF157  in  the  context  of  mammalian  brain development, we took a gene trap approach to disrupt RNF157 protein expression at the systemic  level  in mice. Mouse RNF157 gene  is  located on chromosome 11 with 19 exons and  18  introns.  The  purchased  ES  cell  clone  contains  a  gene  trap  vector  with  a  ßGeo cassette inserted into the second intron of the RNF157 gene, which produces a truncated fusion  mRNA  only  encoding  the  first  2  exons  of  RNF157,  which  do  not  encode  any functional  domains  (Figure  38A).  The  ES  cells  were  injected  into  FVB/N  blastocysts  to obtain  chimeric  animals,  which  were  then  bred  with  C57B/6N mice  to  obtain  germline transmission. To verify offspring carrying the RNF157 gene trap cassette, I performed PCR genotyping (Figure 38B).   
 
Figure 38. Generation of RNF157 gene  trap mice. A) Genomic  structure of  the mouse RNF157 gene. 19 exons and 18 introns are shown, along with the insertion site for the targeting vector. The target vector was inserted into the second intron, as  indicated in the schematic. B) PCR‐based genotyping. Genomic DNA was 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isolated  from  ES  cells  and  subjected  to  PCR  amplification.  Shown  are  two  fragments with  sizes  of  432  bp (WT) and 280 bp (mutant). WT, wild type; Het, heterozygous. 
3.5.2 Analysis of RNF157 transgenic animals   To confirm the reduction of RNF157 in RNF157 heterozygous (Het) animals, Shih‐Ju Lee  prepared  lysates  from  the  adult  cortex  of wild  type  and RNF157 heterozygous mice and subjected them to immunoblotting using the ß‐galactosidase antibody. She found that ß‐galactosidase is expressed in RNF157 Het but not in wild type littermates (Figure 39A). Furthermore,  immunoblotting  of  the  aforementioned  lysates  using  the RNF157  antibody showed a reduction of RNF157 protein  levels  in the RNF157 Het animals as compared to wild type littermates (Figure 39B). These results are consistent with the genotypes defined by PCR‐reaction. 
  
Figure 39. Analysis of RNF157 transgenic animals. A/B) Cortical  lysates of adult RNF157 wild  type and heterozygous  animals  were  immunoblotted  using  the  ß‐galactosidase  (ß‐Gal)  or  RNF157  antibodies, respectively. 14‐3‐3ß served as loading control. WT, wild type; Het, heterozygous.    Next, I crossed RNF157 Het mice to obtain RNF157 homozygous animals. Strikingly, among  166  genotyped  offspring,  none was  homozygous  for  the  gene‐trapped  allele.  The ratio  of wild  type mice  to  heterozygous mice was  around  1:3  (Table  2).  This  raised  the question  if  RNF157  null  embryos  die  during  embryonic  development.  To  answer  this,  I analyzed  embryos  at  E7  and  E10  and  found  that  so  far  neither  at  E7  nor  at  E10  viable homozygous  RNF157  embryos were  detectable.  These  results  suggest  that  disruption  of RNF157 function causes early embryonic lethality of RNF157 homozygous embryos.      Table 2. Genotypes of RNF157 mutant mice or embryos. 
Age  RNF157 WT  RNF157 Het  RNF157 Hom  Total Postnatal  29 (25 %)  87 (75 %)  0  116 E10  3 (33.3 %)  6 (66.6 %)  0  9 E7  13 (31.7%)  28 (68.3 %)  0  41 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 In  summary,  these  results  uncover  an  essential  function  for  RNF157  during embryonic  development  that  is  accompanied  by  the  survival‐promoting  function  of RNF157 in vitro. 
3.5.2.1 Histologic analysis of RNF157 heterozygous mice   To  confirm  the  spatial  expression  pattern  of  RNF157  protein  obtained  by immunoblotting,  Shih‐Ju  Lee  analyzed  the  enzymatic  β‐galactosidase  activity  in  sagittal vibratome  sections  of  RNF157  heterozygous  adult  mice  brains.  She  found  enzymatic  β‐galactosidase activity in cerebellum, midbrain, thalamus, hypothalamus, caudate putamen, anterior olfactory nucleus with high  levels  in  cortex and hippocampus  (Figure 40).  Since the endogenous RNF157 promoter drives the expression of the ßGeo cassette, these results confirm the spatial expression of RNF157 in cortex, cerebellum and hippocampus obtained by immunoblotting using the RNF157 antibody.  
 








   Apoptosis,  a  cell‐intrinsic  suicide program,  is a highly orchestrated process  that  is indispensable to normal development of the central nervous system, while dysregulation of apoptosis  contributes  to  neuronal  loss  observed  in  neurological  injury  and  disease. Growing  evidence  demonstrates  that  the  post‐translational  modification  of  proteins  by ubiquitination  regulates  key  components  of  the  cell  death machinery  (Vucic  et  al,  2011; Whatley et al, 2008). Here, ubiquitination can either regulate the turnover of proteins by proteasome‐dependent  degradation  or  bring  about  important  functional  modifications (Schnell & Hicke, 2003; Vucic et al, 2011). The link between perturbations in ubiquitination and  neurodegenerative  disorders  was  supported  by  the  discoveries  that  loss  of  the  E3 ubiquitin  ligases  Mahogunin  RING  finger‐1  (Mgrn1)  and  LISTERIN  results  in neurodegeneration (Chu et al, 2009; He et al, 2003). However, there is little understanding of  ubiquitination‐dependent  molecular  mechanisms  underlying  both  developmentally regulated  as  well  as  disease‐related  neuronal  apoptosis.  In  the  present  study,  I  have identified  the RING E3  ligase RNF157  as  an  important  regulator  of  neuronal  survival.  In addition, morphological analyses revealed that RNF157 promotes dendrite morphogenesis and complexity in an E3 ligase activity‐independent manner. Furthermore, I have identified the adaptor protein Fe65 as a novel  interactor of RNF157 that operates  in the nucleus to initiate neuronal apoptosis. In addition, Fe65 is a key target of RNF157 and subject to non‐degradative ubiquitination. Consistent with  these  results,  epistasis  analysis  revealed  that Fe65  acts  downstream of  RNF157  in  the  control  of  neuronal  survival.  In  conclusion, my study  uncovers  an  RNF157‐Fe65  pathway  that  regulates  neuronal  survival  in  vitro  and thereby contributes to the understanding of E3 ligases in neuronal survival and apoptosis. In  addition, my work  led  to  the generation of  an RNF157 knockout mouse model, which indicates the importance of RNF157 during embryonic development. 
4.1 RNF157  is a brain­dominant protein  that  is expressed  throughout 
development   The RING finger protein RNF157  is a novel uncharacterized RING E3  ligase.  In my study,  I  found  that  RNF157  is  a  brain‐dominant  protein, which  is  expressed  throughout 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development in cortex, cerebellum and hippocampus. Endogenous RNF157 localizes to the cytoplasm and is absent from the nucleus in neurons. After neuronal polarization, RNF157 is  present  in  the  axon  and  primary  dendrites.  Interestingly,  although  RNF157  mRNA  is detectable in heart, lung and kidney, RNF157 protein however is merely detectable in the brain. This  suggests  that  the  stability of  the RNF157 mRNA varies between different  cell types of the body, which leads to the dominant expression of RNF157 in the brain. In 2009, Jiao  and  colleagues  identified  RNF157  (Mgrn2)  as  a  homologue  of  the  E3  ligase Mgrn1, since they are 69% identical and share high similarities in the N‐terminal region. Although both proteins harbor a conserved RING domain, RNF157 lacks the PSAP tetrapeptide motif, which  is  essential  for  the  interaction  of Mgrn1 with TSG101,  a  component  of  the ESCRT (endosomal  sorting  complex  required  for  transport)  machinery  (Kim  et  al,  2007a). Furthermore, the expression of Mgrn1 is not restricted to the brain, with high expression in heart,  kidney  and  liver  (He  et  al,  2003).  At  the  subcellular  level,  endogenous  Mgrn1  is localized in the nucleus and the cytoplasm, where  it shows a punctuated staining pattern (Kim  et  al,  2007a).  Hence,  although  RNF157  is  a  homologue  of  Mgrn1,  my  results demonstrate  that  the expression and subcellular  localization of RNF157  is different  from Mgrn1 and that RNF157 may have a specific function in the brain.   However, the expression of RNF157 in other regions of the brain as well as during embryonic  development  requires  further  analysis.  In  addition,  it  will  be  interesting  to examine  the  expression  and  localization  of  RNF157  in  astrocytes  and  oligodendrocytes, since RNF157 mRNA is present in cultured astrocytes and in the oligodendrocyte cell line OLI‐neu.   The  Ensembl  project  predicts  three  additional  isoforms  of  RNF157,  which  are smaller  in  size  as  they  differ  in  their  exon  combination.  Analyses  of  their  spatial  and temporal expression as well as their subcellular localization would provide a more detailed view about RNF157 in the brain. In preliminary immunocytochemical experiments, I found that a second RNF157 antibody, which is recognizing a different region within the RNF157 protein,  displays  a  completely different  staining pattern of RNF157  in  cerebellar  granule neurons (data not shown). My results  imply  that  this antibody detects a smaller RNF157 isoform. Accordingly, I hypothesize that the different RNF157 isoforms may differ in their subcellular localization and thus may perform different functions in neurons. 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4.2 RNF157 promotes neuronal survival in vitro   Increasing evidence  identified RING E3  ligases  in neuronal survival and apoptosis, while  their  specific  target  proteins  remain  mostly  unidentified.  In  the  present  study,  I uncovered that the RING E3 ligase RNF157 is an important regulator of neuronal survival. RNF157  loss‐of‐function  dramatically  increases  apoptosis  in  cerebellar  granule  and hippocampal  neurons,  which  could  be  reversed  by  the  expression  of  an  RNAi‐resistant form  of  RNF157,  underscoring  the  specificity  of  the  RNF157  RNAi‐mediated  phenotype. Moreover,  the  RNF157  knockdown‐induced  increase  of  neuronal  cell  death  was suppressed  by  simultaneous  expression  of  the  pro‐survival  Bcl‐2  family member  Bcl‐xL, suggesting  that  knockdown  of  RNF157  leads  to  activation  of  the  apoptotic  machinery. Strikingly,  in  gain‐of‐function  experiments,  wild  type  RNF157  but  not  RNF157  ΔRING increases  neuronal  survival  under  stress  conditions.  This  indicates  that  the  E3  ligase activity  of  RNF157  is  required  for  the  regulation  of  neuronal  survival.  In  summary,  my results  suggest  that  RNF157  regulates  the  survival  of  neurons  in  a  ligase‐dependent manner.  In  future studies,  it will be  interesting to determine  if  the  function of RNF157  is restricted to a specific developmental time window or required during the whole lifespan of  a  neuron.  In  addition,  it  will  be  interesting  to  investigate  if  RNF157  exerts  a  similar function in oligodendrocytes and astrocytes.    Interestingly,  also  Mgrn1  is  important  for  neuronal  survival  in  the  mammalian brain. He  and  colleagues  reported  that Mgrn1 null mice develop progressive  spongiform neurodegeneration  (He et  al,  2003). The  first pathological  changes  appear  at 2 month of age in the CA3 region of the hippocampus and expand to other brain regions at later ages. The Mgrn1 null brain is characterized by vacuolation of the gray matter and neuronal loss in the cerebral cortex, hippocampus, thalamus and brain stem (He et al, 2003). Thus, both RNF157  and  Mgrn1  promote  neuronal  survival.  However,  since  the  Mgrn1  null  mouse displays  severe  defects,  Mgrn1  and  RNF157  are  not  functionally  redundant.  Moreover, while  Mgrn1  was  shown  to  interact  with  TSG101,  a  key  component  of  the  endosomal‐sorting complex, RNF157 does not associate with TSG101 (Jiao et al, 2009). Hence,  these results  suggest  that while Mgrn1  and RNF157  are  important  for  neuronal  survival,  they control different signaling pathways.   In addition to Mgrn1 and RNF157, recent studies implicate other RING E3 ligases in the  regulation  of  neuronal  survival  and  apoptosis  (see  chapter  1.3.1.2).  Nateri  and colleagues reported that the RING E3 ligase SCFFbw7, which mediates the ubiquitination and 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subsequent  degradation  of  phosphorylated  c‐Jun,  has  an  anti‐apoptotic  function  in neurons.  Fbw7  loss‐of‐function  leads  to  accumulation  of  phosphorylated  c‐Jun  and neuronal cell death, which could be reduced by overexpression of  the  JNK  inhibitor  JIP‐1 (Nateri et al, 2004). Furthermore, Sahara and colleagues demonstrated that the U‐box E3 ligase carboxyl terminus of Hsp70‐interacting protein (CHIP) interacts with the molecular chaperone Hsc90  to  ameliorate  tau  aggregation, whereby  the  levels  of  CHIP  are  inverse proportional  to  the  levels  of  aggregated  tau  protein  in  Alzheimer’s  disease  (AD)  brains (Sahara  et  al,  2005).  In  addition,  Shimura  and  colleagues  showed  that  the  CHIP‐Hsc70 complex  ubiquitinates  and  degrades  phosphorylated  tau  in  vitro  thereby  attenuating phosphorylated tau‐induced cell death (Shimura et al, 2004). In contrast to the protective effects  of  RING E3  ligases,  Liu  and  colleagues  reported  that  the RING E3  ligase RNF182, which is upregulated in the brains of AD patients, induces apoptosis. While overexpression of RNF182  in Neuro 2A cells  increases  cell death, RNAi‐mediated knockdown of RNF182 reduces  apoptosis  induced  by  oxygen  and  glucose  deprivation  (OGD).  These  results implicate a role for RNF182 in the initiation of apoptosis (Liu et al, 2008). Another example is  the  RING  E3  ligase  Trim11,  which  was  shown  to  bind  and  destabilize  Humanin,  a neuroprotective peptide,  thereby antagonizing the toxic effects  in AD that are  induced by AD‐linked  mutant  genes  or  the  Aß  peptide  (Hashimoto  et  al,  2001a;  Hashimoto  et  al, 2001b; Hashimoto  et  al,  2001c).  Finally,  Chu  and  colleagues  found  in  a  genome‐wide N‐ethyl‐N‐nitrosourea  (ENU) mutagenesis  screen,  that mutations  in  the  lister  gene  lead  to early‐onset and progression of neurodegeneration and motor dysfunctions. Although lister encodes a RING E3 ligase, LISTERIN, that is ubiquitously expressed, it is motor neurons and neuronal processes  in  the brain stem and spinal  cord  that are primarily affected  in  lister mutant mice. In addition, targeted gene trap insertion revealed that LISTERIN null mice are embryonic  lethal  (Chu  et  al,  2009).  Herewith  the  authors  provide  a  novel  link  between perturbations in ubiquitination and neurodegenerative disorders.   In  summary,  the  aforementioned  examples  demonstrate  the  importance  of  the ubiquitin‐proteasome  system  (UPS)  in  neuronal  viability  and  that  failure  of  the UPS  can lead to a widespread spectrum of neurological disorders (Vucic et al, 2011; Whatley et al, 2008). In this context, my results identify the E3 ligase RNF157 as an important regulator of neuronal  survival  and  thereby  contribute  to  the bigger picture of  the UPS as  a  crucial regulator  of  neuronal  survival  and  apoptosis.  Accordingly,  elucidation  of  the  RNF157‐
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mediated  regulation  of  neuronal  survival  will  improve  our  understanding  of  the  UPS  in neuronal viability. 
4.3 RNF157  is  a  novel  regulator  of  dendrite  growth  independently  of 
its E3 ligase activity   Dendrite  development  is  a  tightly  regulated  and  highly  orchestrated  process. Establishment  of  the  various  neuronal  type‐specific  dendritic  arborization  patterns  is  a hallmark  of  the  neuron  and  essential  for  proper  neuronal  circuit  formation.  Growing evidence demonstrates the importance of cell‐intrinsic signaling pathways in the control of dendrite morphogenesis, but the underlying mechanisms remain poorly understood (Jan & Jan, 2003; Urbanska et al, 2008; Wong & Ghosh, 2002). Over the last decade, an increasing number  of  RING  E3  ligases  have  been  reported  to  control  dendrite  growth  and arborization.  One  of  them  is  the  E3  ligase  Cul7Fbxw8,  which  regulates  Golgi  integrity  and dendrite  patterning  in  cerebellar  granule  neurons  in  vitro  by  ubiquitination  of  the  Golgi protein Grasp65 (Litterman et al, 2011).  In addition, Kim and colleagues showed that the E3  ligase  APC  together  with  its  key  regulatory  subunit  Cdc20  controls  dendrite morphogenesis  in postmitotic neurons by ubiquitination and proteasomal degradation of the transcription factor Id1 (Kim et al, 2009). In the present study, I have identified a novel E3  ligase,  RNF157,  involved  in  the  regulation  of  dendrite  morphogenesis  in  postmitotic neurons  in  vitro.  RNF157  loss‐of‐function  significantly  reduces  dendritic  length  and complexity  in  cerebellar  granule  neurons.  Furthermore,  RNF157  gain‐of‐function significantly  increases  dendrite  growth  and  complexity.  In  addition,  RNF157  loss‐of‐function  in  hippocampal  neurons  reduces  total  dendritic  length  by  85%,  suggesting  that the function of RNF157 represents a generalizable mechanism to regulate dendrite growth in neurons. Interestingly, RNF157 RNAi or RNF157 overexpression has little or no effect on axonal  length.  Thus,  my  results  demonstrate  that  RNF157  specifically  controls  the generation  of  dendrites  but  not  axons  in  different  neuronal  cell  types.  In  addition,  my results suggest that RNF157 contributes to the maintenance of dendritic arborization.    In  contrast  to  the  wealth  of  knowledge  regarding  axonal  and  dendritic morphogenesis,  relatively  little  is  known  about  the  signaling  events, which  regulate  and sustain  synapse and dendrite maintenance.  In  the mammalian brain,  increasing evidence suggests that once a neuron has formed its dendritic arbor, the amount of synaptic inputs from  afferent  neurons  stabilizes  the  existing  branches  and  suppresses  surplus  branch 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growth  (Chen & Nedivi,  2010;  Cline,  2001;  Grueber  &  Sagasti,  2010). Moreover,  various studies  have  identified  that  activity‐dependent  dendrite  maintenance  is  mediated  by calcium‐dependent  signaling  that  regulates  various  downstream  signaling  cascades including  Ca2+/calmodulin‐dependent  protein  kinases  (CaMKs)  and  Rho  family  GTPases (Gaudilliere et al, 2004; Lee et al, 2000). Conversely, various activity‐independent  factors have been  identified  in  the  regulation of dendrite maintenance  (Hoogenraad  et  al,  2005; Wills et al, 2012). For example, direct  interaction of  the synapse scaffold protein PSD‐95 with  the  microtubule  end‐binding  protein  EB3  locally  suppresses  dendrite  branching (Charych et al, 2006; Sweet et al, 2011). Moreover, epigenetic mechanisms and dendrite‐extracellular matrix  (ECM)  interactions were  assumed  to  regulate  dendrite  stability  and maintenance  (Emoto,  2012).  In  contrast,  defects  in  dendrite  maintenance  are  often associated with neurodevelopmental disorders. Reduced dendritic complexity is observed in patients with autism spectrum disorders, schizophrenia and major depressive disorders (MDD)  (Broadbelt  et  al,  2002;  Mukaetova‐Ladinska  et  al,  2004;  Raymond  et  al,  1996). Understanding  of  the molecular  pathways  involved  in  dendrite  growth  and maintenance will  help  to  identify  the  pathological  mechanisms  involved  in  these  neurodegenerative disorders. Hence, in view of these observations, it will be essential to define how RNF157 promotes  dendrite morphogenesis  in  neurons.  Notably, my  results  suggest  that  RNF157 regulates dendrite growth in an E3 ligase activity‐independent manner as overexpression of RNF157 as well as RNF157 ΔRING significantly increases dendritic length in cerebellar granule  neurons.  Interestingly,  other  E3  ligases  have  also  been  shown  to  act  in  an RING domain‐independent  manner.  Sproul  and  colleagues  reported  that  c‐Cbl  acts  as  an apoptotic brake in healthy neuronal cells (Sproul et al, 2009). Upon trophic deprivation, c‐Cbl  protein  levels  rapidly  decrease  and  neuronal  apoptosis  is  induced  by  the  sequential activation of MAP kinase cascades including the MLKs (mixed linage kinases), MKK4 and 7 (mitogen‐activated  protein  kinase  kinases)  and  finally  JNKs  (c‐Jun  N‐terminal  kinases), which leads to phosphorylation and activation of pro‐apoptotic target proteins such as the transcription factor c‐Jun. This effect was mimicked by RNAi‐mediated knockdown of c‐Cbl in  PC12  cells  upon  NGF  deprivation,  while  overexpression  of  c‐Cbl  and  c‐Cbl  ΔRING protects neuronal cells against MLK overexpression‐induced apoptosis. Furthermore, c‐Cbl interacts  with  the  JNK  pathway  components  POSH  and  MLK3  in  heterologous  cells. Interestingly,  the authors  found that c‐Cbl stabilizes MLK3 and suppresses  its capacity  to induce downstream apoptotic signaling. Thus, c‐Cbl inhibits apoptotic signaling in healthy 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neurons  by  blocking  MLK3  downstream  signaling  and  JNK  activation  in  an  E3  ligase activity‐independent manner (Sproul et al, 2009). In another report by Schwammborn and colleagues, Trim32, a homologue of  the Drosophila brat protein, affects proliferation and differentiation  of  neuronal  stem  cells  (NSCs)  by  two  different  signaling  pathways.  In dividing cortical progenitors, Trim32 is enriched in one of the two daughter cells, where it reduces  the  ability  of  NSCs  to  self‐renew  by  ubiquitination  and  degradation  of  c‐Myc, thereby  providing  a  first  step  to  induce  neuronal  differentiation  (Kim  et  al,  2008).  In addition,  Trim32  can  interact with  RNase  Argonaute  1  (Ago1)  to  activate  the MicroRNA Let‐7a  that  is  known  to  regulate  proliferation  in  normal  and  malignant  cells,  and  is upregulated  during  neuronal  differentiation  (Johnson  et  al,  2007;  Peng  et  al,  2008; Sempere et al, 2004; Yu et al, 2007). Hence, it is conceivable that several E3 ligases share a mechanistic concept, in which both ligase‐dependent and independent functions co‐exist. 
4.3.1 Wlds has no effect on the RNF157­knockdown induced dendritic phenotype   The  selective  elimination  of  excessive  neuronal  projections  can  be  found  during developmental  dendrite  pruning  as  well  as  in  response  to  injury‐induced  dendrite degeneration  (Luo  &  O'Leary,  2005;  Tao  &  Rolls,  2011;  Williams  &  Truman,  2005). Although these  two processes  involve similar morphological changes, Tao and colleagues reported  that  they  are  regulated  by molecular  distinct  signaling  pathways  (Tao  &  Rolls, 2011).  Dendrite  pruning  in  Drosophila  ddaC  neurons  involves  the  action  of  apoptotic caspases, Katanin‐p60L1 (Kat‐60L1) (Lee et al, 2009b), IK2 (Lee et al, 2009b), Mical (Kirilly et al, 2009) and a NAD+ signaling pathway to execute the degeneration process. In contrast, the process of injury‐induced dendrite degeneration does neither require the apoptotic nor the  pruning machinery.  However,  the  components  of  the  latter  pathway  require  further research. Wlds was originally identified in the slow Wallerian degeneration mutant mouse where  injury‐induced  axonal  degeneration  is  significantly  delayed  as  compared  to  wild type mice (Lunn et al, 1989). Recent studies have shown that Wlds  is capable of blocking developmental  dendrite  pruning  as  well  as  injury‐induced  dendrite  degeneration (Schoenmann  et  al,  2010;  Tao  &  Rolls,  2011).  However,  while  the mechanism  by which Wlds protects dendrites  is unknown,  it  is assumed  that Wlds  controls NAD+  levels, which leads to a general inhibitory effect of both dendrite pruning and degeneration (Coleman & Freeman, 2010; Tao & Rolls, 2011). In the present study, I found that expression of Wlds in RNF157 knockdown neurons does not inhibit the RNF157 RNAi‐induced reduction in total 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dendritic length. Hence, my results indicate that RNF157 regulates dendrite growth either downstream  or  independently  of  Wlds.  In  the  experimental  setup,  cerebellar  granule neurons were  transfected  at  a  time when  they  already  possesses  dendrites  (DIV  4)  and analyzed four days later. Interestingly, morphological analysis of control neurons between DIV 4‐and 8 revealed that their total dendritic length remains relatively stable in this time window. Accordingly, these findings imply that cerebellar granule neurons do not undergo massive developmental pruning during the analyzed period. Hence, these findings suggest that RNF157 is not involved in dendrite pruning together with Wlds and support the role of RNF157 in dendrite maintenance.  
4.4 Fe65, a novel interactor of RNF157, acts in concert with RNF157 in 
the control of neuronal survival   E3  ligases  mediate  the  post‐translational  modification  of  proteins  by  covalently attaching one or several ubiquitin molecules. Substrate specificity  is brought about by E3 ligases  that  mediate  the  transfer  of  ubiquitin  from  the  E2  conjugating  enzyme  to  the substrate. To identify substrates of RNF157, I carried out an interaction screen that led to the discovery of Fe65. Subsequently,  this  interaction was confirmed both  in heterologous cells and in vivo. While RNF157 binds to the C‐terminal part of Fe65 harboring the second PTB domain, Fe65 interacts with an N‐terminal region of RNF157 (Figure 26).    Fe65 is a member of a multi‐domain adaptor protein family,  including Fe65L1 and Fe65L2,  that  is  encoded  in  humans  by  separate  genes  on  chromosome  11,  4  and  5, respectively (Blanco et al, 1998; Bressler et al, 1996; Tanahashi & Tabira, 1999). Fe65 is a brain‐enriched  protein,  whereby  Fe65L1  and  Fe65L2  are more widely  expressed. While Fe65  null  mice  do  not  show  any  abnormalities,  Fe65/Fe65L1  double  knockout  mice develop  marginal  zone  heterotopias,  middle  crossing  defects  and  axonal  pathfinding abnormalities (Guenette et al, 2006) that resemble the phenotype seen in animals lacking all  three  amyloid  precursor  protein  (APP)  family  members  (Herms  et  al,  2004).  These similarities were  assumed  to be  caused by  a decrease  in APP/Fe65‐dependent  signaling, since  Fe65  regulates  APP  trafficking  and  processing  as  well  as  the  balance  between amyloidogenic  and  non‐amyloidogenic  cleavage  of  APP  (Ando  et  al,  2001;  Borquez  & Gonzalez‐Billault,  2012;  Santiard‐Baron  et  al,  2005).  Similar  to  Fe65  and  RNF157,  the interaction between Fe65 and APP  is mediated by the second PTB domain of Fe65 and a YENPTY reinternalisation signal in the cytoplasmic APP intracellular domain (AICD) (Fiore 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et al, 1995), thereby recruiting Fe65 to cell membranes (Minopoli et al, 2001). Hence, these data  suggest  that  the  binding  of  Fe65  to  APP  is  an  important  regulatory mechanism  to control APP processing and Aß production, which can be influenced by phosphorylation of APP at Thr668 or Tyr682 or by competing with Fe65 for binding to APP (Ando et al, 2001; Barbagallo  et  al,  2010;  Kocherhans  et  al,  2010).  In  future  studies,  it  will  be  of  crucial importance  to  analyze  if  RNF157  regulates  APP  processing  through  interaction  or modification of Fe65. Thus, I speculate that by binding of Fe65 to RNF157, less Fe65 will be available  to  associate  with  APP,  which  may  affect  APP  processing  and  trafficking  in neurons.  
4.4.1 Expression and localization of Fe65 during CNS development   In my study, I analyzed the expression of Fe65 in different regions of the developing mouse  brain.  In  the  cerebellum,  I  found  that  Fe65  protein  levels  increase  during development  with  the  highest  level  of  expression  in  adulthood.  In  contrast,  while  the expression of Fe65 was much weaker and mostly unchanged in the cortex, the expression of Fe65  in  the hippocampus decreased  from E18‐P3 and was unchanged until adulthood. For the adult mouse brain, the expression levels of Fe65 are consistent with earlier in situ 
hybridization  studies  that  demonstrate  a  high  expression  level  of  Fe65  mRNA  in  the hippocampus, cerebellum, olfactory bulb, cortex and habenular nucleus in the adult mouse brain  (Bressler  et  al,  1996).  Furthermore,  Kesavapany  and  colleagues  showed  a widespread Fe65 immunoreactivity  in the adult mouse brain with high immunoreactivity in  cerebellum  and  hippocampus  and  a  decreased  staining  pattern  in  the  neocortex (Kesavapany et al, 2002).  At  the  subcellular  level,  I  found Fe65  immunoreactivity  in  the nucleus, the soma and in the processes of neurons. Although Fe65 has been identified as a strictly  cytoplasmic  protein  (Delatour  et  al,  2001;  Kesavapany  et  al,  2002),  increasing evidence demonstrates a nuclear  localization of endogenous Fe65 in neurons (Barbato et al, 2005; Lau et al, 2008; Minopoli et al, 2001). My results are consistent with the findings by Barbato and colleagues, who showed a somatoneuritic as well as nuclear localization of Fe65 in cerebellar granule and hippocampal neurons (Barbato et al, 2005).    Interestingly,  the  expression  pattern  of  RNF157  is  similar  to  that  of  Fe65  in  the cerebellum.  However,  while  RNF157  levels  decrease  in  adulthood  in  the  cortex,  the expression  of  Fe65  is  unchanged  throughout  development.  Conversely,  while  Fe65 expression decreases during development in the hippocampus, the expression of RNF157 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is  unchanged.  In  addition,  RNF157  and  Fe65  display  an  overlapping  subcellular  staining pattern  in neurons. Hence, my results  indicate  that RNF157 and Fe65 have an  important function together during mammalian brain development. 
4.4.2 Fe65 is ubiquitinated by the E3 ligase RNF157   Since Fe65 was identified as a novel interactor of RNF157, I subsequently analyzed the  ubiquitination  of  Fe65  in  neurons.  My  results  indicate  that  Fe65  is  degraded  in  a proteasome‐dependent manner, since Fe65 levels increase upon selective inhibition of the proteasome  in  cerebellar  granule  neurons.  Interestingly,  Fe65  isolated  from  cultured cerebellar  granule  neurons  harbors  Lys48‐and  Lys63‐linked  ubiquitin  modifications, suggesting  that  Fe65  is  both  marked  for  proteasomal  degradation  as  well  as  in  a  non‐degradative  manner,  which  can  lead  to  changes  in  protein  localization,  activity  or interaction with binding partners (for review see: (Kawabe & Brose, 2011; Schnell & Hicke, 2003). Having confirmed RNF157´s E3 ligase activity, in vitro ubiquitination assays suggest that  RNF157  acts  in  a  complex with  the  E2  UbcH5a  to  either multimonoubiquitinate  or diubiquitinate Fe65 in vitro. Strikingly, no changes in Fe65 protein levels were observed in cortical  lysates  of  RNF157  heterozygous  mice  in  comparison  to  control  littermates (courtesy of S.J Lee). Hence, I conclude that RNF157 regulates the function, interaction or localization  of  Fe65  by  a  non‐degradative  ubiquitin  modification.  Accordingly,  RNF157 does  not  target  Fe65  for  proteasomal  degradation.  Interestingly,  Lee  and  colleagues previously  identified neuronal precursor  cell  expressed developmentally down  regulated (NEDD)  4‐2  as  an  E3  ligase  for  Fe65  and  suggest  that  NEDD4‐2  targets  Fe65  for proteasomal  degradation  (Lee  et  al,  2009a).  This  is  accompanied  by  the  Lys48‐linked polyubiquitination  of  Fe65  and  would  explain  the  accumulation  of  Fe65  seen  upon inhibition  of  the  proteasome.  Since  proteins  can  be  targeted  by  independent  E3  ligases (Amati, 2004; Nishitani et al, 2006), it is conceivable that Fe65 is targeted for proteasomal degradation by NEDD4‐2, whereas ubiquitination of Fe65 by RNF157 leads to a regulatory modification of Fe65 in neurons.   Proteasome‐independent ubiquitin modifications have been further shown for other E3  ligases  (Komander & Rape, 2012;  Schnell & Hicke, 2003). Among  those,  the E3  ligase neuronal precursor cell expressed and developmentally downregulated protein (Nedd) 4‐1 regulates dendrite outgrowth and complexity in a trimeric complex with Rap2a and TNIK by mono‐or diubiquitination of Rap2a, thereby blocking the activity of Rap2a, which in turn 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leads  to  reduced  activity  of  downstream effector  kinases  of  the TNIK  family  followed by dendrite  outgrowth.  Thus,  ubiquitination  of  Rap2a  by  Nedd4‐1  regulates  the  activity  of Rap2a (Kawabe et al, 2010). In addition, monoubiquitination of p53 by the E3 ligase Mdm2 induces  its  export  from  the nucleus, which  is  assumed  to be mediated by  changes  in  the accessibility of  the nuclear export  signal of p53  to  the export machinery  (Li  et  al, 2003). Thus,  it  is  conceivable  that  the RNF157‐mediated mono‐or diubiquitination of  Fe65 may modulate the subcellular localization of Fe65 in neurons or the ability of Fe65 to bind to its interaction partners APP, LRP or Tip60 (reviewed in: (Borquez & Gonzalez‐Billault, 2012)). Interestingly,  the  E3  ligase  Mgrn1  was  shown  to  multimonoubiquitinate  TSG101,  a  key component  of  the  ESCRT‐I  complex  (Kim  et  al,  2007a),  which  suggests  that monoubiquitination might be a general feature of the E3 ligases RNF157 and Mgrn1.   In  future  experiments,  it  will  be  important  the  bolster  the  finding  that  Fe65  is  a substrate  of  RNF157  by  demonstrating  that  the  RING  domain  is  instrumental  to  Fe65 ubiquitination  and  by  identifying  the  target  lysine(s)  of  Fe65,  which  act  as  ubiquitin acceptors.  Finally,  it  will  be  important  to  determine  if  RNF157  mediates  mono‐or diubiquitination of Fe65 using a polymerization‐defective ubiquitin mutant. 
4.4.3 RNF157 and Fe65 act in a linear pathway to control neuronal survival   The  E3  ligase  RNF157  was  uncovered  as  a  novel  regulator  of  dendrite morphogenesis and neuronal survival  in vitro.  In addition,  I  identified  the brain‐enriched adaptor  protein  Fe65  as  a  novel  interactor  of  RNF157.  In  vitro  ubiquitination  assays indicate  that  RNF157  ubiquitinates  Fe65  in  a  non‐proteolytic  manner.  Consistent  with these  results,  epistasis  analysis  of  RNF157  and  Fe65  in  neurons  suggest  that  Fe65  acts downstream of RNF157 in the control of neuronal survival. While overexpression of Fe65 triggers  cell  death,  RNAi‐mediated  knockdown  of  Fe65  significantly  reduces  starvation‐induced  apoptosis  in  cerebellar  granule  neurons.  My  findings  further  demonstrate  that Fe65  operates  in  the  nucleus  to  initiate  neuronal  apoptosis.  These  results  were accompanied  by  structure‐function  analysis,  which  show  that  nuclear  Fe65  dramatically increases cell death  in cerebellar granule neurons.  In  summary, my  findings suggest  that RNF157  and  Fe65  are  components  of  a  cell‐intrinsic  signaling  pathway  that  controls neuronal survival.   In future studies, it will be important to gain further insight into the RNF157‐Fe65 underlying  mechanism  regulating  neuronal  survival.  Interestingly,  Fe65  was  shown  to 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activate  together  with  APP  the  transcriptional  activity  of  the  histone  acetyltransferase Tip60  (Cao  &  Sudhof,  2001).  Fe65  is  assumed  to  adopt  a  closed  conformation  in  the cytoplasm,  which  can  be  reversed  by  binding  to  the  cytoplasmatic  tail  of  APP  (AICD), followed  by  the  recruitment  and  phosphorylation  of  Tip60  by  cyclin‐dependent  kinases (CDKs) (Cao & Sudhof, 2004; Hass & Yankner, 2005; Lemercier et al, 2003). The release of the  complex  from  the  plasma membrane  in  response  to  DNA  damage,  cellular  stress  or other  unknown  stimuli  can  be  induced  via  two  complementary  mechanisms:  either  by subsequent  cleavage  of  APP  by  ß‐and  γ‐secretase  or  by  the  phosphorylation  of  APP  at Thr668 or Tyr682, which attenuates the binding affinity between Fe65 and APP (Ando et al,  2001;  Barbagallo  et  al,  2010;  Cao  &  Sudhof,  2001;  Nakaya  &  Suzuki,  2006; Radzimanowski et al, 2008). The complex then translocates to the nucleus to regulate gene expression,  repair  of  DNA  double  strand‐breaks  (DSB)  and  apoptosis  (Baek  et  al,  2002; Gaughan  et  al,  2001;  Ikura  et  al,  2000;  Kimberly  et  al,  2001;  Kinoshita  et  al,  2002a; Kinoshita et  al,  2002b; Passer et  al,  2000).  In addition,  the  induction of  apoptosis by  the AICD/Fe65/Tip60  signaling pathway  involves  the upregulation of  pro‐apoptotic  proteins including  p53  (Alves  da  Costa  et  al,  2006;  Kim  et  al,  2007b;  Kinoshita  et  al,  2002a). Interestingly,  Kim  and  colleagues  reported  that  the  intracellular  domain  of  Notch  1 (Notch1‐IC)  suppresses  AICD‐induced  cell  death  of  neuroblastoma  cells  by  physical disruption  of  the  AICD/Fe65/Tip60  complex  (Kim  et  al,  2007b).  In  view  of  these observations, I hypothesize that the RNF157‐mediated ubiquitination of Fe65 may lead to the following consequences: (I) Interaction of RNF157 with Fe65 competes for the binding of Fe65 to APP, thereby diminishing phosphorylation and activation of Tip60. (II) While the C‐terminal Fe65 fragment (Fe65aa525‐711) translocates to the nucleus and induces apoptosis, Fe65aa326‐711 is equally distributed within the cell and only shows a moderate induction of apoptosis.  In  addition,  Fe65  is  ubiquitinated  by  RNF157  in  a  non‐degradative  manner. Hence, I postulate that ubiquitination of Fe65 by RNF157 regulates the localization of Fe65. Accordingly,  ubiquitination  of  Fe65  might  inhibit  nuclear  translocation  of  Fe65,  which inhibits  the  activation  of  transcription  mediated  by  Tip60,  thereby  preventing  the induction of  apoptosis  (Figure 42).  This  is  supported by  the work  from Cao  and  Südhof, who  showed  that  cytoplasmic  NES‐Fe65  together  with  APP  was  unable  to  activate transcription  in  a  Gal4‐Tip60  transactivation  assay.  In  contrast,  translocation  of  AICD  in this  context  was  apparently  unnecessary  for  activation  of  transcription  (Cao  &  Sudhof, 2004).  
Discussion 
97 
  To  confirm  this  putative  signaling  pathway,  it will  be  essential  to  elucidate  if  the RNF157‐Fe65  pathway  regulates  neuronal  survival  together  with  APP  or  Tip60. Furthermore,  it  will  be  important  to  determine  if  ubiquitination  of  Fe65  by  RNF157 inhibits  its  nuclear  translocation,  thereby  suppressing  the  transcription  of  pro‐apoptotic target genes. In this context, it will be crucial to analyze the localization of Fe65 in neurons of  RNF157 wild  type  and  heterozygous  animals  to  verify  that  ubiquitination  of  Fe65  by RNF157 affects its localization in neurons.  
4.4.3.1 RNF157  and  death  receptor  6  (DR6)  act  in  a  linear  pathway  to  control 




function   The  UPS  has  been  implicated  in  a  plethora  of  different  signaling  events  in  the mammalian brain (Kawabe & Brose, 2011; Tuoc & Stoykova, 2010; Yi & Ehlers, 2007).  In particular,  there  is  increasing  evidence  that  E3  ligases  control  important  aspects  of neuronal  development  including  neurogenesis,  migration,  neuritogenesis  and  synapse formation (Kawabe & Brose, 2011). In this study, the E3 ligase RNF157 has been identified as an important regulator of dendrite morphogenesis and neuronal survival in postmitotic neurons in vitro. Complementary, an RNF157 gene trap mouse model was generated in this work  to  elucidate  the  in  vivo  physiological  function  of  RNF157  in  mammalian  brain development.   Analysis  of  RNF157  heterozygous mice  showed  a  reduction  of  RNF157 protein  in the  brain  of  adult  mice.  Interestingly,  RNF157  heterozygous  animals  seemed  to  be physically  healthy  and  showed  no  changes  in  the  gross  morphology  of  the  brain  in comparison to wild type littermates. Subsequently, PCR‐genotyped RNF157 heterozygous mice were crossed to obtain homozygous mice. Among the genotyped postnatal littermates (P5  and  3 weeks),  none were  homozygous  for  the  trapped  allele.  Subsequently,  RNF157 embryos  at  E10  and  E7 were  analyzed.  However,  so  far  none were  homozygous  for  the trapped allele. Hence, these results suggest that disruption of RNF157 function causes early embryonic  lethality  of  RNF157  homozygous  embryos  (Table  2)  and  that  RNF157  is essential during mammalian embryonic development. Deletion of Mgrn1 exhibits a similar effect on embryonic viability, which is the result of congenital heart defects and abnormal patterning of the Right‐Left axis (He et al, 2003; Phillips, 1963). The surviving Mgrn1 null mice display other phenotypes including dark pigmentation and adult‐onset of progressive spongiform  neurodegeneration  (He  et  al,  2003).  Hence,  these  findings  demonstrate  the crucial importance of RNF157 and Mgrn1 during embryonic development   In  future studies,  it will be  important  to define at which stage deletion of RNF157 disrupts  embryonic  development.  Thus,  further  expression  analyses  of  RNF157  during embryonic development are required. Since  the RNF157 heterozygous mice survive until adulthood,  it  will  be  important  to  analyze  if  they  develop  age‐dependent neurodegeneration as reported for Mgrn1 homozygous mice. Moreover, behavioral tests of RNF157 heterozygous mice grant further insight into the function of RNF157 in the brain. 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Figure  42.  A  working  model  for  the  E3  ligase  RNF157  and  its  novel  interactor  Fe65  in  neuronal 








Symbols  and  colors.  High‐consensus  color=red;  Low  consensus  color=blue;  Neutral color=black.  A  highly  conserved  residue  appears  in  high‐consensus  color  and  as  an uppercase  letter  in  the  consensus  line.  A  weakly  conserved  residue  appears  in  low‐consensus color and as a  lowercase letter  in the consensus line. Other 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appear 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neutral  color.  A  position  with  no  conserved 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 is  represented  by  a  dot  in  the consensus line. The second conserved in‐frame start codon is highlighted by a black square. Black line indicates the different N‐terminal sequences of mouse, human and rat RNF157. The RING domain is shaded in grey. 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